{"parse":{"title":"Circulating tumor DNA","pageid":44690654,"revid":860380729,"text":{"*":"<div class=\"mw-parser-output\"><div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:502px;\"><a href=\"/wiki/File:CtDNA_in_circulation.png\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/CtDNA_in_circulation.png/500px-CtDNA_in_circulation.png\" width=\"500\" height=\"358\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/0/0f/CtDNA_in_circulation.png 1.5x\" data-file-width=\"726\" data-file-height=\"520\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:CtDNA_in_circulation.png\" class=\"internal\" title=\"Enlarge\"></a></div>Circulating tumor DNA (ctDNA) is found in <a href=\"/wiki/Serum_(blood)\" title=\"Serum (blood)\">serum</a> and <a href=\"/wiki/Blood_plasma\" title=\"Blood plasma\">plasma</a> fractions from <a href=\"/wiki/Blood\" title=\"Blood\">blood</a>. The mechanism of ctDNA release is unknown, though <a href=\"/wiki/Apoptosis\" title=\"Apoptosis\">apoptosis</a>, <a href=\"/wiki/Necrosis\" title=\"Necrosis\">necrosis</a>, and active secretion from tumor cells have been hypothesized. Once ctDNA is isolated, it can be sequenced for mutational analysis.</div></div></div>\n<p><b>Circulating tumor DNA</b> (ctDNA) is <a href=\"/wiki/Tumor\" class=\"mw-redirect\" title=\"Tumor\">tumor</a>-derived fragmented <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a> in the bloodstream that is not associated with cells. ctDNA should not be confused with cell-free DNA (cfDNA), a broader term which describes DNA that is freely circulating in the bloodstream, but is not necessarily of tumor origin. Because ctDNA may reflect the entire tumor <a href=\"/wiki/Genome\" title=\"Genome\">genome</a>, it has gained traction for its potential clinical utility; \u201c<a href=\"/wiki/Liquid_biopsy\" title=\"Liquid biopsy\">liquid biopsies</a>\u201d in the form of blood draws may be taken at various time points to monitor tumor progression throughout the treatment regimen.\n</p><p>ctDNA originates directly from the tumor or from <a href=\"/wiki/Circulating_tumor_cell\" title=\"Circulating tumor cell\">circulating tumor cells</a> (CTCs),<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup> which describes viable, intact tumor cells that shed from primary tumors and enter the bloodstream or <a href=\"/wiki/Lymphatic\" class=\"mw-redirect\" title=\"Lymphatic\">lymphatic</a> system. The precise mechanism of ctDNA release is unclear. The biological processes postulated to be involved in ctDNA release include <a href=\"/wiki/Apoptosis\" title=\"Apoptosis\">apoptosis</a> and <a href=\"/wiki/Necrosis\" title=\"Necrosis\">necrosis</a> from dying cells, or active release from viable tumor cells.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> Studies in both human (healthy and cancer patients)<sup id=\"cite_ref-:6_7-0\" class=\"reference\"><a href=\"#cite_note-:6-7\">&#91;7&#93;</a></sup> and xenografted mice<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> show that the size of fragmented cfDNA is predominantly 166bp long, which corresponds to the length of DNA wrapped around a <a href=\"/wiki/Nucleosome\" title=\"Nucleosome\">nucleosome</a> plus a linker. Fragmentation of this length is indicative of <a href=\"/wiki/Apoptotic_DNA_fragmentation\" title=\"Apoptotic DNA fragmentation\">apoptotic DNA fragmentation</a>, suggesting that apoptosis may be the primary method of ctDNA release.\n</p><p>In healthy tissue, infiltrating <a href=\"/wiki/Phagocyte\" title=\"Phagocyte\">phagocytes</a> are responsible for clearance of apoptotic or necrotic cellular debris, which includes cfDNA.<sup id=\"cite_ref-:0_9-0\" class=\"reference\"><a href=\"#cite_note-:0-9\">&#91;9&#93;</a></sup> Levels of cfDNA in healthy patients is only present at low levels but higher levels of ctDNA in cancer patients can be detected. This possibly occurs due to inefficient immune cell infiltration to tumor sites, which reduces effective clearance of ctDNA from the bloodstream.<sup id=\"cite_ref-:0_9-1\" class=\"reference\"><a href=\"#cite_note-:0-9\">&#91;9&#93;</a></sup>\n</p><p><br />\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Methods\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Methods</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Pre-analytical_Considerations\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Pre-analytical Considerations</span></a></li>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Extraction_of_ctDNA\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">Extraction of ctDNA</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Analysis_of_ctDNA\"><span class=\"tocnumber\">1.3</span> <span class=\"toctext\">Analysis of ctDNA</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-5\"><a href=\"#Untargeted_approaches\"><span class=\"tocnumber\">1.3.1</span> <span class=\"toctext\">Untargeted approaches</span></a>\n<ul>\n<li class=\"toclevel-4 tocsection-6\"><a href=\"#Digital_Karyotyping\"><span class=\"tocnumber\">1.3.1.1</span> <span class=\"toctext\">Digital Karyotyping</span></a></li>\n<li class=\"toclevel-4 tocsection-7\"><a href=\"#Personalized_analysis_of_rearranged_ends_(PARE)\"><span class=\"tocnumber\">1.3.1.2</span> <span class=\"toctext\">Personalized analysis of rearranged ends (PARE)</span></a></li>\n<li class=\"toclevel-4 tocsection-8\"><a href=\"#DNA_Methylation_and_Hydroxymethylation\"><span class=\"tocnumber\">1.3.1.3</span> <span class=\"toctext\">DNA Methylation and Hydroxymethylation</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-3 tocsection-9\"><a href=\"#Targeted_approaches\"><span class=\"tocnumber\">1.3.2</span> <span class=\"toctext\">Targeted approaches</span></a>\n<ul>\n<li class=\"toclevel-4 tocsection-10\"><a href=\"#Digital_droplet_PCR_(ddPCR)\"><span class=\"tocnumber\">1.3.2.1</span> <span class=\"toctext\">Digital droplet PCR (ddPCR)</span></a></li>\n<li class=\"toclevel-4 tocsection-11\"><a href=\"#Beads,_Emulsification,_Amplification,_and_Magnetics_(BEAMing)\"><span class=\"tocnumber\">1.3.2.2</span> <span class=\"toctext\">Beads, Emulsification, Amplification, and Magnetics (BEAMing)</span></a></li>\n<li class=\"toclevel-4 tocsection-12\"><a href=\"#CAncer_Personalized_Profiling_by_deep_Sequencing_(CAPP-Seq)\"><span class=\"tocnumber\">1.3.2.3</span> <span class=\"toctext\">CAncer Personalized Profiling by deep Sequencing (CAPP-Seq)</span></a></li>\n<li class=\"toclevel-4 tocsection-13\"><a href=\"#Tagged_AMplicon_deep_Sequencing_(TAM-Seq)\"><span class=\"tocnumber\">1.3.2.4</span> <span class=\"toctext\">Tagged AMplicon deep Sequencing (TAM-Seq)</span></a></li>\n<li class=\"toclevel-4 tocsection-14\"><a href=\"#Safe-Sequencing_(Safe-Seq)\"><span class=\"tocnumber\">1.3.2.5</span> <span class=\"toctext\">Safe-Sequencing (Safe-Seq)</span></a></li>\n<li class=\"toclevel-4 tocsection-15\"><a href=\"#Duplex_sequencing\"><span class=\"tocnumber\">1.3.2.6</span> <span class=\"toctext\">Duplex sequencing</span></a></li>\n<li class=\"toclevel-4 tocsection-16\"><a href=\"#Integrated_Digital_Error_Suppression_(iDES)-enhanced_CAPP-Seq\"><span class=\"tocnumber\">1.3.2.7</span> <span class=\"toctext\">Integrated Digital Error Suppression (iDES)-enhanced CAPP-Seq</span></a></li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-17\"><a href=\"#Considerations\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Considerations</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-18\"><a href=\"#\u201cNormal\u201d_vs_tumor_DNA_detection\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">\u201cNormal\u201d vs tumor DNA detection</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-19\"><a href=\"#Research\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Research</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-20\"><a href=\"#ctDNA_in_cancer_screening\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">ctDNA in cancer screening</span></a></li>\n<li class=\"toclevel-2 tocsection-21\"><a href=\"#ctDNA_in_cancer_monitoring\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">ctDNA in cancer monitoring</span></a></li>\n<li class=\"toclevel-2 tocsection-22\"><a href=\"#ctDNA_as_a_prognostic_biomarker\"><span class=\"tocnumber\">3.3</span> <span class=\"toctext\">ctDNA as a prognostic biomarker</span></a></li>\n<li class=\"toclevel-2 tocsection-23\"><a href=\"#Cancer_research\"><span class=\"tocnumber\">3.4</span> <span class=\"toctext\">Cancer research</span></a></li>\n<li class=\"toclevel-2 tocsection-24\"><a href=\"#Challenges_for_implementation\"><span class=\"tocnumber\">3.5</span> <span class=\"toctext\">Challenges for implementation</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-25\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-26\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-27\"><a href=\"#Further_reading\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Further reading</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Methods\">Methods</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=1\" title=\"Edit section: Methods\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Pre-analytical_Considerations\">Pre-analytical Considerations</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=2\" title=\"Edit section: Pre-analytical Considerations\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>When blood is collected in EDTA tubes and stored the white blood cells begin to lyse and release genomic wild type DNA in to the sample in quantities typically many fold higher than the ctDNA is present in.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup> This makes detection of mutations or other ctDNA biomarkers more difficult.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> The use of commercially available cell stabilisation tubes can prevent or delay the lysis of white cells thereby reducing the dilution effect of the ctDNA.<sup id=\"cite_ref-pmid26918901_12-0\" class=\"reference\"><a href=\"#cite_note-pmid26918901-12\">&#91;12&#93;</a></sup> Sherwood et al demonstrated superior detection of <i>KRAS</i> mutations in matched samples collected in both EDTA K3 and Streck BCT tubes.<sup id=\"cite_ref-pmid26918901_12-1\" class=\"reference\"><a href=\"#cite_note-pmid26918901-12\">&#91;12&#93;</a></sup> The advantages of cell stabilisation tubes can be realised in situation where blood cannot be processed to plasma immediately.\n</p><p>Other procedures can also reduce the amount of \"contaminating\" wild type DNA and make detection of ctDNA more feasible:<sup id=\"cite_ref-pmid26918901_12-2\" class=\"reference\"><a href=\"#cite_note-pmid26918901-12\">&#91;12&#93;</a></sup>\n</p>\n<ul><li>Never freeze a blood sample before extracting the plasma for ctDNA analysis</li>\n<li>Process the sample to plasma within 2\u20134 hours (if collected in EDTA tube)</li>\n<li>Never use heparinised tubes, heparin inhibits PCR by mimicking the helical structure of DNA</li>\n<li>Perform a double centrifugation step (centrifuge the blood to remove plasma, then repeat on the plasma to remove from debris in the bottom of the tube) to remove more cellular debris prior to DNA extraction.</li>\n<li>Plasma is better than serum for ctDNA recovery<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup></li></ul>\n<h3><span class=\"mw-headline\" id=\"Extraction_of_ctDNA\">Extraction of ctDNA</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=3\" title=\"Edit section: Extraction of ctDNA\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The main appeal of ctDNA analysis is that it is extracted in a non-invasive manner through blood collection. Acquisition of cfDNA or ctDNA typically requires collection of approximately 3mL of blood into <a href=\"/wiki/Edta\" class=\"mw-redirect\" title=\"Edta\">EDTA</a>-coated tubes. The use of EDTA is important to reduce coagulation of blood. The <a href=\"/wiki/Blood_plasma\" title=\"Blood plasma\">plasma</a> and <a href=\"/wiki/Serum_(blood)\" title=\"Serum (blood)\">serum</a> fractions of blood can be separated through a centrifugation step. ctDNA or cfDNA can be subsequently extracted from these fractions. Although serum tends to have greater levels of cfDNA, this is primarily attributed to DNA from lymphocytes.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> High levels of contaminating cfDNA is sub-optimal because this can decrease the sensitivity of ctDNA detection. Therefore, the majority of studies use plasma for ctDNA isolation. Plasma is then processed again by centrifugation to remove residual intact blood cells. The supernatant is used for DNA extraction, which can be performed using commercially available kits.\n</p>\n<h3><span class=\"mw-headline\" id=\"Analysis_of_ctDNA\">Analysis of ctDNA</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=4\" title=\"Edit section: Analysis of ctDNA\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The analysis of ctDNA after extraction requires the use of various amplification and sequencing methods. These methods can be separated into two main groups based on whether the goal is to interrogate all genes in an untargeted approach, or if the goal is to monitor specific genes and mutations in a targeted approach.\n</p>\n<h4><span class=\"mw-headline\" id=\"Untargeted_approaches\">Untargeted approaches</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=5\" title=\"Edit section: Untargeted approaches\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>A whole genome or whole exome sequencing approaches may be necessary to discover new mutations in tumor DNA while monitoring disease burden or tracking drug resistance.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> Untargeted approaches are also useful in research to observe tumor heterogeneity or to discover new drug targets. However, while untargeted methods may be necessary in certain applications, it is more expensive and has lower resolution. This makes it difficult to detect rare mutations, or in situations where low ctDNA levels are present (such as minimal residual disease). Furthermore,  there can be problems distinguishing between DNA from tumor cells and DNA from normal cells using a whole genome approach.\n</p><p>Whole genome or exome sequencing typically use <a href=\"/wiki/High_throughput_sequencing\" class=\"mw-redirect\" title=\"High throughput sequencing\">high throughput DNA sequencing technologies</a>. Limiting the sequencing to only the whole exome instead can decrease expense and increase speed, but at the cost of losing information about mutations in the non-coding regulatory regions of DNA.<sup id=\"cite_ref-:3_16-0\" class=\"reference\"><a href=\"#cite_note-:3-16\">&#91;16&#93;</a></sup> While simply looking at DNA polymorphisms through sequencing does not differentiate DNA from tumor or normal cells, this problem can be resolved by comparing against a control sample of normal DNA (for example, DNA obtained through a <a href=\"/wiki/Buccal_swab\" title=\"Buccal swab\">buccal swab</a>.) Importantly, whole genome and whole exome sequencing are useful for initial mutation discovery. This provides information for the use of more sensitive targeted techniques, which can then be used for disease monitoring purposes.\n</p>\n<h5><span class=\"mw-headline\" id=\"Digital_Karyotyping\">Digital Karyotyping</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=6\" title=\"Edit section: Digital Karyotyping\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>Unlike normal <a href=\"/wiki/Karyotype\" title=\"Karyotype\">karyotyping</a> where a dye is used to stain chromosomal bands in order to visualize the chromosomes, digital karyotyping uses DNA sequences of loci throughout the genome in order to calculate <a href=\"/wiki/Copy-number_variation\" title=\"Copy-number variation\">copy number variation</a>.<sup id=\"cite_ref-:5_17-0\" class=\"reference\"><a href=\"#cite_note-:5-17\">&#91;17&#93;</a></sup> Copy number variations are common in cancers and describe situations where  loss of heterozygosity of a gene may lead to decreased function due to lower expression, or duplication of a gene, which leads to overexpression.\n</p>\n<h5><span id=\"Personalized_analysis_of_rearranged_ends_.28PARE.29\"></span><span class=\"mw-headline\" id=\"Personalized_analysis_of_rearranged_ends_(PARE)\">Personalized analysis of rearranged ends (PARE)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=7\" title=\"Edit section: Personalized analysis of rearranged ends (PARE)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>After the whole genome is sequenced using a high throughput sequencing method, such as Illumina HiSeq, PARE is applied to the data to analyze chromosomal rearrangements and translocations. This technique was originally designed to analyze solid tumor DNA but was modified for ctDNA applications.<sup id=\"cite_ref-:5_17-1\" class=\"reference\"><a href=\"#cite_note-:5-17\">&#91;17&#93;</a></sup>\n</p>\n<h5><span class=\"mw-headline\" id=\"DNA_Methylation_and_Hydroxymethylation\">DNA Methylation and Hydroxymethylation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=8\" title=\"Edit section: DNA Methylation and Hydroxymethylation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>Proper <a href=\"/wiki/Epigenetics\" title=\"Epigenetics\">epigenetic</a> marking is essential for normal gene expression and cell function and aberrant alterations in epigenetic patterns is a hallmark of cancer.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup> A normal epigenetic status is maintained in a cell at least in part through <a href=\"/wiki/DNA_methylation\" title=\"DNA methylation\">DNA methylation</a>.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>  Measuring aberrant methylation patterns in ctDNA is possible due to stable methylation of regions of DNA referred to as \u201c<a href=\"/wiki/CpG_islands\" class=\"mw-redirect\" title=\"CpG islands\">CpG islands</a>\u201d. Methylation of ctDNA can be detected through <a href=\"/wiki/Bisulfite_sequencing\" title=\"Bisulfite sequencing\">bisulfite treatment</a>. Bisulfite treatment chemically converts unmethylated cytosines into a uracil while leaving methylated cytosines unmodified. DNA is subsequently sequenced, and any alterations to the DNA methylation pattern can be identified. DNA hydroxymethylation is a similarly associated mark that has been shown to be a predictive marker of healthy versus diseased conditions in cfDNA, including cancer. Measuring aberrant hydroxymethylation patterns in ctDNA has been proven by researchers at University of Chicago (Chuan He lab,<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup>) Stanford University (Quake lab,<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup>) and the company <a href=\"/w/index.php?title=Cambridge_Epigenetix&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Cambridge Epigenetix (page does not exist)\">Cambridge Epigenetix</a>.\n</p>\n<h4><span class=\"mw-headline\" id=\"Targeted_approaches\">Targeted approaches</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=9\" title=\"Edit section: Targeted approaches\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>In a targeted approach, sequencing of ctDNA can be directed towards a genetic panel constructed based on mutational hotspots for the cancer of interest. This is especially important for informing treatment in situations where mutations are identified in druggable targets.<sup id=\"cite_ref-:3_16-1\" class=\"reference\"><a href=\"#cite_note-:3-16\">&#91;16&#93;</a></sup> Personalizing targeted analysis of ctDNA to each patient is also possible by combining liquid biopsies with standard primary tissue biopsies. Whole genome or whole exome sequencing of the primary tumor biopsy allows for discovery of genetic mutations specific to a patient\u2019s tumor, and can be used for subsequent targeted sequencing of the patient\u2019s ctDNA. The highest sensitivity of ctDNA detection is accomplished through targeted sequencing of specific <a href=\"/wiki/Single-nucleotide_polymorphism\" title=\"Single-nucleotide polymorphism\">single nucleotide polymorphisms</a> (SNPs). Commonly mutated genes, such as oncogenes, which typically have hotspot mutations, are good candidates for targeted sequencing approaches. Conversely, most tumor suppressor genes have a wide array of possible loss of function mutations throughout the gene, and as such are not suitable for targeted sequencing.\n</p><p>Targeted approaches have the advantage of amplifying ctDNA through <a href=\"/wiki/Polymerase_chain_reaction\" title=\"Polymerase chain reaction\">polymerase chain reactions</a> (PCR) or <a href=\"/wiki/Digital_polymerase_chain_reaction\" title=\"Digital polymerase chain reaction\">digital PCR</a>. This is especially important when analyzing ctDNA not only because there are relatively low levels of DNA circulating in the bloodstream, but also because ctDNA makes up a small proportion of the total cell-free DNA extracted.<sup id=\"cite_ref-:3_16-2\" class=\"reference\"><a href=\"#cite_note-:3-16\">&#91;16&#93;</a></sup> Therefore, amplification of regions of interest can drastically improve sensitivity of ctDNA detection. However, amplification through PCR can introduce errors given the inherent error rate of DNA polymerases. Errors introduced during sequencing can also decrease the sensitivity of detecting ctDNA mutations.\n</p>\n<h5><span id=\"Digital_droplet_PCR_.28ddPCR.29\"></span><span class=\"mw-headline\" id=\"Digital_droplet_PCR_(ddPCR)\"><a href=\"/wiki/Digital_polymerase_chain_reaction\" title=\"Digital polymerase chain reaction\">Digital droplet PCR</a> (ddPCR)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=10\" title=\"Edit section: Digital droplet PCR (ddPCR)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>Digital droplet PCR utilizes a droplet generator to partition single pieces of DNA into droplets using an oil/water emulsion. Then individual polymerase chain reactions occur in each droplet using selected primers against regions of ctDNA and proceeds to endpoint. The presence of the sequences of interest is measured by fluorescent probes, which bind to the amplified region. ddPCR allows for highly quantitative assessment of allele and mutant frequencies in ctDNA but is limited by the number of fluorescent probes that can be used in one assay (up to 5).<sup id=\"cite_ref-:2_22-0\" class=\"reference\"><a href=\"#cite_note-:2-22\">&#91;22&#93;</a></sup> The sensitivity of the assay can vary depending on the amount of DNA analyzed and is around 1 in 10,000.<sup id=\"cite_ref-:2_22-1\" class=\"reference\"><a href=\"#cite_note-:2-22\">&#91;22&#93;</a></sup>\n</p>\n<h5><span id=\"Beads.2C_Emulsification.2C_Amplification.2C_and_Magnetics_.28BEAMing.29\"></span><span class=\"mw-headline\" id=\"Beads,_Emulsification,_Amplification,_and_Magnetics_(BEAMing)\">Beads, Emulsification, Amplification, and Magnetics (<a href=\"/wiki/BEAMing\" title=\"BEAMing\">BEAMing</a>)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=11\" title=\"Edit section: Beads, Emulsification, Amplification, and Magnetics (BEAMing)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>This technique builds upon digital droplet PCR in order to identify mutations in ctDNA using flow cytometry.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup> After ctDNA is extracted from blood, PCR is performed with primers designed to target the regions of interest. These primers also contain specific DNA sequences, or tags. The amplified DNA is mixed with streptavidin-coated magnetic beads and emulsified into droplets. Biotinylated primers designed to bind to the tags are used to amplify the DNA. Biotinylation allows the amplified DNA to bind to the magnetic beads, which are coated with streptavidin. After the PCR is complete, the DNA-bound beads are separated using a magnet. The DNA on the beads are then denatured and allowed to hybridize with fluorescent oligonucleotides specific to each DNA template. The resulting bead-DNA complexes are then analyzed using flow cytometry. This technique is able to capture allele and mutation frequencies due to coupling with ddPCR. However, unlike with ddPCR, a larger number of DNA sequences can be interrogated due to the flexibility of using fluorescently bound probes. Another advantage of this system is that the DNA isolated can also be used for downstream sequencing.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup> Sensitivity is 1.6 in 10,000 to 4.3 in 100,000.<sup id=\"cite_ref-:2_22-2\" class=\"reference\"><a href=\"#cite_note-:2-22\">&#91;22&#93;</a></sup>\n</p>\n<h5><span id=\"CAncer_Personalized_Profiling_by_deep_Sequencing_.28CAPP-Seq.29\"></span><span class=\"mw-headline\" id=\"CAncer_Personalized_Profiling_by_deep_Sequencing_(CAPP-Seq)\"><a href=\"/wiki/CAPP-Seq\" title=\"CAPP-Seq\">CAncer Personalized Profiling by deep Sequencing</a> (CAPP-Seq)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=12\" title=\"Edit section: CAncer Personalized Profiling by deep Sequencing (CAPP-Seq)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>This technique uses biotinylated oligonucleotide selector probes to target sequences of DNA relevant to ctDNA detection.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup> Publicly available cancer databases were used to construct a library of probes against recurrent mutations in cancer by calculating their recurrence index. The protocol was optimized for the low DNA levels observed in ctDNA collection. Then the isolated DNA undergoes deep sequencing for increased sensitivity. This technique allows for the interrogation of hundreds of DNA regions. The ctDNA detection sensitivity of CAPP-Seq is reported to be 2.5 molecules in 1,000,000.<sup id=\"cite_ref-Newman_2016_26-0\" class=\"reference\"><a href=\"#cite_note-Newman_2016-26\">&#91;26&#93;</a></sup>\n</p>\n<h5><span id=\"Tagged_AMplicon_deep_Sequencing_.28TAM-Seq.29\"></span><span class=\"mw-headline\" id=\"Tagged_AMplicon_deep_Sequencing_(TAM-Seq)\">Tagged AMplicon deep Sequencing (TAM-Seq)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=13\" title=\"Edit section: Tagged AMplicon deep Sequencing (TAM-Seq)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>TAM-Seq allows targeted sequencing of entire genes to detect mutations in ctDNA.<sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup> First a general amplification step is performed using primers that span the entire gene of interest in 150-200bp sections. Then, a microfluidics system is used to attached adaptors with a unique identifier to each amplicon to further amplify the DNA in parallel singleplex reactions. This technique was shown to successfully identify mutations scattered in the TP53 tumor suppressor gene in advanced ovarian cancer patients. The sensitivity of this technique is 1 in 50.\n</p>\n<h5><span id=\"Safe-Sequencing_.28Safe-Seq.29\"></span><span class=\"mw-headline\" id=\"Safe-Sequencing_(Safe-Seq)\">Safe-Sequencing (Safe-Seq)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=14\" title=\"Edit section: Safe-Sequencing (Safe-Seq)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>Safe-Seq decreases the error rate of massively parallel sequencing in order to increase the sensitivity to rare mutants.<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup> It achieves this by addition of a unique identifier (UID) sequence to each DNA template. The DNA is then amplified using the added UIDs and sequenced. All DNA molecules with the same UID (a UID family) should have the same reported DNA sequence since they were amplified from one molecule. However, mutations can be introduced through amplification, or incorrect base assignments may be called in the sequencing and analysis steps. The presence of the UID allows these methodology errors to be separated from true mutations of the ctDNA. A mutation is considered a \u2018supermutant\u2019 if 95% of the sequenced reads are in agreement. The sensitivity of this approach is 9 in 1 million.<sup id=\"cite_ref-:2_22-3\" class=\"reference\"><a href=\"#cite_note-:2-22\">&#91;22&#93;</a></sup>\n</p>\n<h5><span class=\"mw-headline\" id=\"Duplex_sequencing\"><a href=\"/wiki/Duplex_sequencing\" title=\"Duplex sequencing\">Duplex sequencing</a></span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=15\" title=\"Edit section: Duplex sequencing\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>This method is an improvement on the single UIDs added in the Safe-Seq technique.<sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup> In duplex sequencing, randomized double-stranded DNA act as unique tags and are attached to an invariant spacer. Tags are attached to both ends of a DNA fragment (\u03b1 and \u03b2 tags), which results in two unique templates for PCR - one strand with an \u03b1 tag on the 5\u2019 end and a \u03b2 tag on the 3\u2019 end and the other strand with a \u03b2 tag on the 5\u2019 end and an \u03b1 tag on the 3\u2019 end. These DNA fragments are then amplified with primers against the invariant sequences of the tags. The  amplified DNA is sequenced and analyzed. DNA with the duplex adaptors are compared and mutations are only accepted if there is a consensus between both strands. This method takes into account both errors from sequencing and errors from early stage PCR amplification. The sensitivity of the approach to discovering mutants is 1 in 10^7.\n</p>\n<h5><span id=\"Integrated_Digital_Error_Suppression_.28iDES.29-enhanced_CAPP-Seq\"></span><span class=\"mw-headline\" id=\"Integrated_Digital_Error_Suppression_(iDES)-enhanced_CAPP-Seq\">Integrated Digital Error Suppression (iDES)-enhanced CAPP-Seq</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=16\" title=\"Edit section: Integrated Digital Error Suppression (iDES)-enhanced CAPP-Seq\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>iDES improves CAPP-Seq analysis of ctDNA in order to decrease error and therefore increase sensitivity of detection.<sup id=\"cite_ref-Newman_2016_26-1\" class=\"reference\"><a href=\"#cite_note-Newman_2016-26\">&#91;26&#93;</a></sup> Reported in 2016, iDES combines CAPP-Seq with duplex barcoding sequencing technology and with a computational algorithm that removes stereotypical errors associated with the CAPP-Seq hybridization step. The sensitivity of this improved version of CAPP-Seq is 4 in 100,000 copies.\n</p>\n<h2><span class=\"mw-headline\" id=\"Considerations\">Considerations</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=17\" title=\"Edit section: Considerations\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span id=\".E2.80.9CNormal.E2.80.9D_vs_tumor_DNA_detection\"></span><span class=\"mw-headline\" id=\"\u201cNormal\u201d_vs_tumor_DNA_detection\">\u201cNormal\u201d vs tumor DNA detection</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=18\" title=\"Edit section: \u201cNormal\u201d vs tumor DNA detection\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>One of the challenges in using ctDNA as a cancer biomarker is whether ctDNA can be distinguished with cfDNA from normal cells. cfDNA is released by non-malignant cells during normal cellular turnover, but also during procedures such as <a href=\"/wiki/Surgery\" title=\"Surgery\">surgery</a>, <a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">radiotherapy</a>, or <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapy</a>. It is thought that lymphocytes are the primary contributors to cfDNA in serum.<sup id=\"cite_ref-:3_16-3\" class=\"reference\"><a href=\"#cite_note-:3-16\">&#91;16&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Research\">Research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=19\" title=\"Edit section: Research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"ctDNA_in_cancer_screening\">ctDNA in cancer screening</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=20\" title=\"Edit section: ctDNA in cancer screening\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The clinical utility of ctDNA for the detection of primary disease is in part limited by the sensitivity of current technology; there are low levels of ctDNA present, and driver mutations are unknown.<sup id=\"cite_ref-:2_22-4\" class=\"reference\"><a href=\"#cite_note-:2-22\">&#91;22&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"ctDNA_in_cancer_monitoring\">ctDNA in cancer monitoring</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=21\" title=\"Edit section: ctDNA in cancer monitoring\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Evidence of disease by traditional imaging methods, such as <a href=\"/wiki/CT_scan\" title=\"CT scan\">CT</a>, <a href=\"/wiki/Positron_emission_tomography\" title=\"Positron emission tomography\">PET</a> or <a href=\"/wiki/Magnetic_resonance_imaging\" title=\"Magnetic resonance imaging\">MRI</a> may be absent after tumor resection. Therefore, ctDNA analysis poses a potential avenue to detect <a href=\"/wiki/Minimal_residual_disease\" title=\"Minimal residual disease\">minimal residual disease</a> (MRD), and thus the possibility of tumor recurrence, in cases where bulk tumor is absent by conventional imaging methods. A comparison of MRD detection by CT imaging compared to ctDNA has been previously done in individuals with stage II colon cancer; in this study, researchers were able to detect ctDNA in individuals who showed no sign of clinical malignancy by a CT scan, suggesting that ctDNA detection has greater sensitivity to assess MRD.<sup id=\"cite_ref-:3_16-4\" class=\"reference\"><a href=\"#cite_note-:3-16\">&#91;16&#93;</a></sup> However, the authors acknowledge that ctDNA analysis is not without limitations; plasma samples collected post-operatively were only able to predict recurrence at 36 months in 48% of cases.<sup id=\"cite_ref-:3_16-5\" class=\"reference\"><a href=\"#cite_note-:3-16\">&#91;16&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"ctDNA_as_a_prognostic_biomarker\">ctDNA as a prognostic biomarker</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=22\" title=\"Edit section: ctDNA as a prognostic biomarker\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The question of whether measurement of the amount or qualities of ctDNA could be used to determine outcomes in people with cancer has been a subject of study. As of 2015 this was very uncertain.<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup>  Although some studies have shown a trend of higher ctDNA levels in people with high stage metastatic cancer, ctDNA burden does not always correlate with traditional cancer staging.<sup id=\"cite_ref-:2_22-5\" class=\"reference\"><a href=\"#cite_note-:2-22\">&#91;22&#93;</a></sup>  As of 2017 it appeared unlikely that ctDNA would be of clinical utility as a sole predictor of prognosis.<sup id=\"cite_ref-:4_31-0\" class=\"reference\"><a href=\"#cite_note-:4-31\">&#91;31&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Cancer_research\">Cancer research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=23\" title=\"Edit section: Cancer research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The emergence of drug-resistant tumors due to intra- and inter-tumoral heterogeneity an issue in treatment efficacy. A minor genetic clone within the tumor can expand after treatment if it carries a drug-resistant mutation. Initial biopsies can miss these clones due to low frequency or spatial separation of cells within the tumor. For example, since a biopsy only samples a small part of the tumor, clones that resides in a different location may go unnoticed. This can mislead research that focuses on studying the role of tumor heterogeneity in cancer progression and relapse. The use of ctDNA in research can alleviate these concerns because it could provide a more representative 'screenshot' of the genetic diversity of cancer at both primary and metastatic sites. For example, ctDNA has been shown to be useful in studying the clonal evolution of a patient\u2019s cancer before and after treatment regimens.<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Challenges_for_implementation\">Challenges for implementation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=24\" title=\"Edit section: Challenges for implementation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Implementation of ctDNA in clinical practice is largely hindered by the lack of standardized methods for ctDNA processing and analysis. Standardization of methods for sample collection (including time of collection), downstream processing (DNA extraction and amplification), quantification and validation must be established before ctDNA analysis can become a routine clinical assay. Furthermore, creation of a panel of \u2018standard\u2019 tumor-associated biomarkers may be necessary given the resolution of current ctDNA sequencing and detection methods. Sequencing tumor-specific aberrations from plasma samples may also help exclude contaminating cfDNA from analysis; elevated levels of cfDNA from normal cells may be attributed to non-cancer related causes.<sup id=\"cite_ref-:3_16-6\" class=\"reference\"><a href=\"#cite_note-:3-16\">&#91;16&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=25\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><a href=\"/wiki/Circulating_mitochondrial_DNA\" title=\"Circulating mitochondrial DNA\">Circulating mitochondrial DNA</a>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=26\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Akca H, Demiray A, Yaren A, Bir F, Koseler A, Iwakawa R, Bagci G, Yokota J (March 2013). \"Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer\". <i>Cancer Genetics</i>. <b>206</b> (3): 73\u201380. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.cancergen.2013.01.005\">10.1016/j.cancergen.2013.01.005</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23491080\">23491080</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Genetics&amp;rft.atitle=Utility+of+serum+DNA+and+pyrosequencing+for+the+detection+of+EGFR+mutations+in+non-small+cell+lung+cancer&amp;rft.volume=206&amp;rft.issue=3&amp;rft.pages=73-80&amp;rft.date=2013-03&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cancergen.2013.01.005&amp;rft_id=info%3Apmid%2F23491080&amp;rft.aulast=Akca&amp;rft.aufirst=H&amp;rft.au=Demiray%2C+A&amp;rft.au=Yaren%2C+A&amp;rft.au=Bir%2C+F&amp;rft.au=Koseler%2C+A&amp;rft.au=Iwakawa%2C+R&amp;rft.au=Bagci%2C+G&amp;rft.au=Yokota%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Schwarzenbach H, Hoon DS, Pantel K (June 2011). <span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/nrc3066\">\"Cell-free nucleic acids as biomarkers in cancer patients\"<span style=\"padding-left:0.15em\"><img alt=\"Paid subscription required\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/9px-Lock-red-alt.svg.png\" title=\"Paid subscription required\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/14px-Lock-red-alt.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/18px-Lock-red-alt.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span></a></span>. <i>Nature Reviews. Cancer</i>. <b>11</b> (6): 426\u201337. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrc3066\">10.1038/nrc3066</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21562580\">21562580</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Cancer&amp;rft.atitle=Cell-free+nucleic+acids+as+biomarkers+in+cancer+patients&amp;rft.volume=11&amp;rft.issue=6&amp;rft.pages=426-37&amp;rft.date=2011-06&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc3066&amp;rft_id=info%3Apmid%2F21562580&amp;rft.aulast=Schwarzenbach&amp;rft.aufirst=H&amp;rft.au=Hoon%2C+DS&amp;rft.au=Pantel%2C+K&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fnrc3066&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stroun M, Anker P (July 1972). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1173871\">\"Nucleic acids spontaneously released by living frog auricles\"</a>. <i>The Biochemical Journal</i>. <b>128</b> (3): 100P\u2013101P. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1173871\">1173871</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4634816\">4634816</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Biochemical+Journal&amp;rft.atitle=Nucleic+acids+spontaneously+released+by+living+frog+auricles&amp;rft.volume=128&amp;rft.issue=3&amp;rft.pages=100P-101P&amp;rft.date=1972-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1173871&amp;rft_id=info%3Apmid%2F4634816&amp;rft.aulast=Stroun&amp;rft.aufirst=M&amp;rft.au=Anker%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1173871&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P (November 2001). <span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencedirect.com/science/article/pii/S0009898101006659\">\"About the possible origin and mechanism of circulating DNA apoptosis and active DNA release\"<span style=\"padding-left:0.15em\"><img alt=\"Paid subscription required\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/9px-Lock-red-alt.svg.png\" title=\"Paid subscription required\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/14px-Lock-red-alt.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/18px-Lock-red-alt.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span></a></span>. <i>Clinica Chimica Acta; International Journal of Clinical Chemistry</i>. <b>313</b> (1-2): 139\u201342. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0009-8981%2801%2900665-9\">10.1016/S0009-8981(01)00665-9</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11694251\">11694251</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinica+Chimica+Acta%3B+International+Journal+of+Clinical+Chemistry&amp;rft.atitle=About+the+possible+origin+and+mechanism+of+circulating+DNA+apoptosis+and+active+DNA+release&amp;rft.volume=313&amp;rft.issue=1-2&amp;rft.pages=139-42&amp;rft.date=2001-11&amp;rft_id=info%3Adoi%2F10.1016%2FS0009-8981%2801%2900665-9&amp;rft_id=info%3Apmid%2F11694251&amp;rft.aulast=Stroun&amp;rft.aufirst=M&amp;rft.au=Lyautey%2C+J&amp;rft.au=Lederrey%2C+C&amp;rft.au=Olson-Sand%2C+A&amp;rft.au=Anker%2C+P&amp;rft_id=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0009898101006659&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Anker P, Stroun M, Maurice PA (September 1975). <a rel=\"nofollow\" class=\"external text\" href=\"http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=1149042\">\"Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system\"</a>. <i>Cancer Research</i>. <b>35</b> (9): 2375\u201382. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1149042\">1149042</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Spontaneous+release+of+DNA+by+human+blood+lymphocytes+as+shown+in+an+in+vitro+system&amp;rft.volume=35&amp;rft.issue=9&amp;rft.pages=2375-82&amp;rft.date=1975-09&amp;rft_id=info%3Apmid%2F1149042&amp;rft.aulast=Anker&amp;rft.aufirst=P&amp;rft.au=Stroun%2C+M&amp;rft.au=Maurice%2C+PA&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D1149042&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rogers JC, Boldt D, Kornfeld S, Skinner A, Valeri CR (July 1972). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC426778\">\"Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen\"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>69</b> (7): 1685\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.69.7.1685\">10.1073/pnas.69.7.1685</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC426778\">426778</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4505646\">4505646</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Excretion+of+deoxyribonucleic+acid+by+lymphocytes+stimulated+with+phytohemagglutinin+or+antigen&amp;rft.volume=69&amp;rft.issue=7&amp;rft.pages=1685-9&amp;rft.date=1972-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC426778&amp;rft_id=info%3Apmid%2F4505646&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.69.7.1685&amp;rft.aulast=Rogers&amp;rft.aufirst=JC&amp;rft.au=Boldt%2C+D&amp;rft.au=Kornfeld%2C+S&amp;rft.au=Skinner%2C+A&amp;rft.au=Valeri%2C+CR&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC426778&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:6-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-:6_7-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Heitzer E, Auer M, Hoffmann EM, Pichler M, Gasch C, Ulz P, Lax S, Waldispuehl-Geigl J, Mauermann O, Mohan S, Pristauz G, Lackner C, H\u00f6fler G, Eisner F, Petru E, Sill H, Samonigg H, Pantel K, Riethdorf S, Bauernhofer T, Geigl JB, Speicher MR (July 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3708119\">\"Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer\"</a>. <i>International Journal of Cancer</i>. <b>133</b> (2): 346\u201356. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/ijc.28030\">10.1002/ijc.28030</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3708119\">3708119</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23319339\">23319339</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Cancer&amp;rft.atitle=Establishment+of+tumor-specific+copy+number+alterations+from+plasma+DNA+of+patients+with+cancer&amp;rft.volume=133&amp;rft.issue=2&amp;rft.pages=346-56&amp;rft.date=2013-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3708119&amp;rft_id=info%3Apmid%2F23319339&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.28030&amp;rft.aulast=Heitzer&amp;rft.aufirst=E&amp;rft.au=Auer%2C+M&amp;rft.au=Hoffmann%2C+EM&amp;rft.au=Pichler%2C+M&amp;rft.au=Gasch%2C+C&amp;rft.au=Ulz%2C+P&amp;rft.au=Lax%2C+S&amp;rft.au=Waldispuehl-Geigl%2C+J&amp;rft.au=Mauermann%2C+O&amp;rft.au=Mohan%2C+S&amp;rft.au=Pristauz%2C+G&amp;rft.au=Lackner%2C+C&amp;rft.au=H%C3%B6fler%2C+G&amp;rft.au=Eisner%2C+F&amp;rft.au=Petru%2C+E&amp;rft.au=Sill%2C+H&amp;rft.au=Samonigg%2C+H&amp;rft.au=Pantel%2C+K&amp;rft.au=Riethdorf%2C+S&amp;rft.au=Bauernhofer%2C+T&amp;rft.au=Geigl%2C+JB&amp;rft.au=Speicher%2C+MR&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3708119&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Thierry AR, Mouliere F, Gongora C, Ollier J, Robert B, Ychou M, Del Rio M, Molina F (October 2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2952865\">\"Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts\"</a>. <i>Nucleic Acids Research</i>. <b>38</b> (18): 6159\u201375. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/nar/gkq421\">10.1093/nar/gkq421</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2952865\">2952865</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20494973\">20494973</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nucleic+Acids+Research&amp;rft.atitle=Origin+and+quantification+of+circulating+DNA+in+mice+with+human+colorectal+cancer+xenografts&amp;rft.volume=38&amp;rft.issue=18&amp;rft.pages=6159-75&amp;rft.date=2010-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2952865&amp;rft_id=info%3Apmid%2F20494973&amp;rft_id=info%3Adoi%2F10.1093%2Fnar%2Fgkq421&amp;rft.aulast=Thierry&amp;rft.aufirst=AR&amp;rft.au=Mouliere%2C+F&amp;rft.au=Gongora%2C+C&amp;rft.au=Ollier%2C+J&amp;rft.au=Robert%2C+B&amp;rft.au=Ychou%2C+M&amp;rft.au=Del+Rio%2C+M&amp;rft.au=Molina%2C+F&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2952865&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:0-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pisetsky DS, Fairhurst AM (June 2007). <span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.tandfonline.com/doi/full/10.1080/08916930701358826\">\"The origin of extracellular DNA during the clearance of dead and dying cells\"<span style=\"padding-left:0.15em\"><img alt=\"Paid subscription required\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/9px-Lock-red-alt.svg.png\" title=\"Paid subscription required\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/14px-Lock-red-alt.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/18px-Lock-red-alt.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span></a></span>. <i>Autoimmunity</i>. <b>40</b> (4): 281\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1080/08916930701358826\">10.1080/08916930701358826</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17516210\">17516210</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Autoimmunity&amp;rft.atitle=The+origin+of+extracellular+DNA+during+the+clearance+of+dead+and+dying+cells&amp;rft.volume=40&amp;rft.issue=4&amp;rft.pages=281-4&amp;rft.date=2007-06&amp;rft_id=info%3Adoi%2F10.1080%2F08916930701358826&amp;rft_id=info%3Apmid%2F17516210&amp;rft.aulast=Pisetsky&amp;rft.aufirst=DS&amp;rft.au=Fairhurst%2C+AM&amp;rft_id=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Ffull%2F10.1080%2F08916930701358826&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Xue X, Teare MD, Holen I, Zhu YM, Woll PJ (June 2009). \"Optimizing the yield and utility of circulating cell-free DNA from plasma and serum\". <i>Clinica Chimica Acta; International Journal of Clinical Chemistry</i>. <b>404</b> (2): 100\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.cca.2009.02.018\">10.1016/j.cca.2009.02.018</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19281804\">19281804</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinica+Chimica+Acta%3B+International+Journal+of+Clinical+Chemistry&amp;rft.atitle=Optimizing+the+yield+and+utility+of+circulating+cell-free+DNA+from+plasma+and+serum&amp;rft.volume=404&amp;rft.issue=2&amp;rft.pages=100-4&amp;rft.date=2009-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cca.2009.02.018&amp;rft_id=info%3Apmid%2F19281804&amp;rft.aulast=Xue&amp;rft.aufirst=X&amp;rft.au=Teare%2C+MD&amp;rft.au=Holen%2C+I&amp;rft.au=Zhu%2C+YM&amp;rft.au=Woll%2C+PJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Norton SE, Lechner JM, Williams T, Fernando MR (October 2013). \"A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR\". <i>Clinical Biochemistry</i>. <b>46</b> (15): 1561\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.clinbiochem.2013.06.002\">10.1016/j.clinbiochem.2013.06.002</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23769817\">23769817</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Biochemistry&amp;rft.atitle=A+stabilizing+reagent+prevents+cell-free+DNA+contamination+by+cellular+DNA+in+plasma+during+blood+sample+storage+and+shipping+as+determined+by+digital+PCR&amp;rft.volume=46&amp;rft.issue=15&amp;rft.pages=1561-5&amp;rft.date=2013-10&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clinbiochem.2013.06.002&amp;rft_id=info%3Apmid%2F23769817&amp;rft.aulast=Norton&amp;rft.aufirst=SE&amp;rft.au=Lechner%2C+JM&amp;rft.au=Williams%2C+T&amp;rft.au=Fernando%2C+MR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid26918901-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid26918901_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid26918901_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid26918901_12-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sherwood JL, Corcoran C, Brown H, Sharpe AD, Musilova M, Kohlmann A (2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4769175\">\"Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)\"</a>. <i>PLOS One</i>. <b>11</b> (2): e0150197. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1371/journal.pone.0150197\">10.1371/journal.pone.0150197</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4769175\">4769175</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26918901\">26918901</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+One&amp;rft.atitle=Optimised+Pre-Analytical+Methods+Improve+KRAS+Mutation+Detection+in+Circulating+Tumour+DNA+%28ctDNA%29+from+Patients+with+Non-Small+Cell+Lung+Cancer+%28NSCLC%29&amp;rft.volume=11&amp;rft.issue=2&amp;rft.pages=e0150197&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4769175&amp;rft_id=info%3Apmid%2F26918901&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0150197&amp;rft.aulast=Sherwood&amp;rft.aufirst=JL&amp;rft.au=Corcoran%2C+C&amp;rft.au=Brown%2C+H&amp;rft.au=Sharpe%2C+AD&amp;rft.au=Musilova%2C+M&amp;rft.au=Kohlmann%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4769175&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vall\u00e9e A, Marcq M, Bizieux A, Kouri CE, Lacroix H, Bennouna J, Douillard JY, Denis MG (November 2013). \"Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients\". <i>Lung Cancer</i>. <b>82</b> (2): 373\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.lungcan.2013.08.014\">10.1016/j.lungcan.2013.08.014</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24007628\">24007628</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lung+Cancer&amp;rft.atitle=Plasma+is+a+better+source+of+tumor-derived+circulating+cell-free+DNA+than+serum+for+the+detection+of+EGFR+alterations+in+lung+tumor+patients&amp;rft.volume=82&amp;rft.issue=2&amp;rft.pages=373-4&amp;rft.date=2013-11&amp;rft_id=info%3Adoi%2F10.1016%2Fj.lungcan.2013.08.014&amp;rft_id=info%3Apmid%2F24007628&amp;rft.aulast=Vall%C3%A9e&amp;rft.aufirst=A&amp;rft.au=Marcq%2C+M&amp;rft.au=Bizieux%2C+A&amp;rft.au=Kouri%2C+CE&amp;rft.au=Lacroix%2C+H&amp;rft.au=Bennouna%2C+J&amp;rft.au=Douillard%2C+JY&amp;rft.au=Denis%2C+MG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lee TH, Montalvo L, Chrebtow V, Busch MP (February 2001). \"Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma\". <i>Transfusion</i>. <b>41</b> (2): 276\u201382. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1046/j.1537-2995.2001.41020276.x\">10.1046/j.1537-2995.2001.41020276.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11239235\">11239235</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Transfusion&amp;rft.atitle=Quantitation+of+genomic+DNA+in+plasma+and+serum+samples%3A+higher+concentrations+of+genomic+DNA+found+in+serum+than+in+plasma&amp;rft.volume=41&amp;rft.issue=2&amp;rft.pages=276-82&amp;rft.date=2001-02&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1537-2995.2001.41020276.x&amp;rft_id=info%3Apmid%2F11239235&amp;rft.aulast=Lee&amp;rft.aufirst=TH&amp;rft.au=Montalvo%2C+L&amp;rft.au=Chrebtow%2C+V&amp;rft.au=Busch%2C+MP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Qin Z, Ljubimov VA, Zhou C, Tong Y, Liang J (April 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4823888\">\"Cell-free circulating tumor DNA in cancer\"</a>. <i>Chinese Journal of Cancer</i>. <b>35</b>: 36. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/s40880-016-0092-4\">10.1186/s40880-016-0092-4</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4823888\">4823888</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27056366\">27056366</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chinese+Journal+of+Cancer&amp;rft.atitle=Cell-free+circulating+tumor+DNA+in+cancer&amp;rft.volume=35&amp;rft.pages=36&amp;rft.date=2016-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4823888&amp;rft_id=info%3Apmid%2F27056366&amp;rft_id=info%3Adoi%2F10.1186%2Fs40880-016-0092-4&amp;rft.aulast=Qin&amp;rft.aufirst=Z&amp;rft.au=Ljubimov%2C+VA&amp;rft.au=Zhou%2C+C&amp;rft.au=Tong%2C+Y&amp;rft.au=Liang%2C+J&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4823888&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:3-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:3_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:3_16-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:3_16-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:3_16-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:3_16-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-:3_16-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-:3_16-6\"><sup><i><b>g</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Heitzer E, Ulz P, Geigl JB (January 2015). \"Circulating tumor DNA as a liquid biopsy for cancer\". <i>Clinical Chemistry</i>. <b>61</b> (1): 112\u201323. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1373/clinchem.2014.222679\">10.1373/clinchem.2014.222679</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25388429\">25388429</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Chemistry&amp;rft.atitle=Circulating+tumor+DNA+as+a+liquid+biopsy+for+cancer&amp;rft.volume=61&amp;rft.issue=1&amp;rft.pages=112-23&amp;rft.date=2015-01&amp;rft_id=info%3Adoi%2F10.1373%2Fclinchem.2014.222679&amp;rft_id=info%3Apmid%2F25388429&amp;rft.aulast=Heitzer&amp;rft.aufirst=E&amp;rft.au=Ulz%2C+P&amp;rft.au=Geigl%2C+JB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:5-17\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:5_17-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:5_17-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Leary RJ, Sausen M, Kinde I, Papadopoulos N, Carpten JD, Craig D, O'Shaughnessy J, Kinzler KW, Parmigiani G, Vogelstein B, Diaz LA, Velculescu VE (November 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3641759\">\"Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing\"</a>. <i>Science Translational Medicine</i>. <b>4</b> (162): 162ra154. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/scitranslmed.3004742\">10.1126/scitranslmed.3004742</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3641759\">3641759</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23197571\">23197571</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science+Translational+Medicine&amp;rft.atitle=Detection+of+chromosomal+alterations+in+the+circulation+of+cancer+patients+with+whole-genome+sequencing&amp;rft.volume=4&amp;rft.issue=162&amp;rft.pages=162ra154&amp;rft.date=2012-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3641759&amp;rft_id=info%3Apmid%2F23197571&amp;rft_id=info%3Adoi%2F10.1126%2Fscitranslmed.3004742&amp;rft.aulast=Leary&amp;rft.aufirst=RJ&amp;rft.au=Sausen%2C+M&amp;rft.au=Kinde%2C+I&amp;rft.au=Papadopoulos%2C+N&amp;rft.au=Carpten%2C+JD&amp;rft.au=Craig%2C+D&amp;rft.au=O%27Shaughnessy%2C+J&amp;rft.au=Kinzler%2C+KW&amp;rft.au=Parmigiani%2C+G&amp;rft.au=Vogelstein%2C+B&amp;rft.au=Diaz%2C+LA&amp;rft.au=Velculescu%2C+VE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3641759&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Preobrazhenski\u012d BS (1966). \"[Current perspectives and the method of systematic treatment of cochlear neuritis and chronic labyrinthopathy]\". <i>Vestnik Otorinolaringologii</i> (in Russian). <b>28</b> (1): 3\u201311. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/5988180\">5988180</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vestnik+Otorinolaringologii&amp;rft.atitle=%5BCurrent+perspectives+and+the+method+of+systematic+treatment+of+cochlear+neuritis+and+chronic+labyrinthopathy%5D&amp;rft.volume=28&amp;rft.issue=1&amp;rft.pages=3-11&amp;rft.date=1966&amp;rft_id=info%3Apmid%2F5988180&amp;rft.aulast=Preobrazhenski%C4%AD&amp;rft.aufirst=BS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Beaumont G, Dobbins S, Latta D, McMillin WP (May 1990). \"Mequitazine in the treatment of hayfever\". <i>The British Journal of Clinical Practice</i>. <b>44</b> (5): 183\u20138. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1975200\">1975200</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+British+Journal+of+Clinical+Practice&amp;rft.atitle=Mequitazine+in+the+treatment+of+hayfever&amp;rft.volume=44&amp;rft.issue=5&amp;rft.pages=183-8&amp;rft.date=1990-05&amp;rft_id=info%3Apmid%2F1975200&amp;rft.aulast=Beaumont&amp;rft.aufirst=G&amp;rft.au=Dobbins%2C+S&amp;rft.au=Latta%2C+D&amp;rft.au=McMillin%2C+WP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Li W, Zhang X, Lu X, You L, Song Y, Luo Z,  et al. (October 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5630683\">\"5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers\"</a>. <i>Cell Research</i>. <b>27</b> (10): 1243\u20131257. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/cr.2017.121\">10.1038/cr.2017.121</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5630683\">5630683</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28925386\">28925386</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell+Research&amp;rft.atitle=5-Hydroxymethylcytosine+signatures+in+circulating+cell-free+DNA+as+diagnostic+biomarkers+for+human+cancers&amp;rft.volume=27&amp;rft.issue=10&amp;rft.pages=1243-1257&amp;rft.date=2017-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5630683&amp;rft_id=info%3Apmid%2F28925386&amp;rft_id=info%3Adoi%2F10.1038%2Fcr.2017.121&amp;rft.aulast=Li&amp;rft.aufirst=W&amp;rft.au=Zhang%2C+X&amp;rft.au=Lu%2C+X&amp;rft.au=You%2C+L&amp;rft.au=Song%2C+Y&amp;rft.au=Luo%2C+Z&amp;rft.au=Zhang%2C+J&amp;rft.au=Nie%2C+J&amp;rft.au=Zheng%2C+W&amp;rft.au=Xu%2C+D&amp;rft.au=Wang%2C+Y&amp;rft.au=Dong%2C+Y&amp;rft.au=Yu%2C+S&amp;rft.au=Hong%2C+J&amp;rft.au=Shi%2C+J&amp;rft.au=Hao%2C+H&amp;rft.au=Luo%2C+F&amp;rft.au=Hua%2C+L&amp;rft.au=Wang%2C+P&amp;rft.au=Qian%2C+X&amp;rft.au=Yuan%2C+F&amp;rft.au=Wei%2C+L&amp;rft.au=Cui%2C+M&amp;rft.au=Zhang%2C+T&amp;rft.au=Liao%2C+Q&amp;rft.au=Dai%2C+M&amp;rft.au=Liu%2C+Z&amp;rft.au=Chen%2C+G&amp;rft.au=Meckel%2C+K&amp;rft.au=Adhikari%2C+S&amp;rft.au=Jia%2C+G&amp;rft.au=Bissonnette%2C+MB&amp;rft.au=Zhang%2C+X&amp;rft.au=Zhao%2C+Y&amp;rft.au=Zhang%2C+W&amp;rft.au=He%2C+C&amp;rft.au=Liu%2C+J&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5630683&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Song CX, Yin S, Ma L, Wheeler A, Chen Y, Zhang Y, Liu B, Xiong J, Zhang W, Hu J, Zhou Z, Dong B, Tian Z, Jeffrey SS, Chua MS, So S, Li W, Wei Y, Diao J, Xie D, Quake SR (October 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5630676\">\"5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages\"</a>. <i>Cell Research</i>. <b>27</b> (10): 1231\u20131242. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/cr.2017.106\">10.1038/cr.2017.106</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5630676\">5630676</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28820176\">28820176</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell+Research&amp;rft.atitle=5-Hydroxymethylcytosine+signatures+in+cell-free+DNA+provide+information+about+tumor+types+and+stages&amp;rft.volume=27&amp;rft.issue=10&amp;rft.pages=1231-1242&amp;rft.date=2017-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5630676&amp;rft_id=info%3Apmid%2F28820176&amp;rft_id=info%3Adoi%2F10.1038%2Fcr.2017.106&amp;rft.aulast=Song&amp;rft.aufirst=CX&amp;rft.au=Yin%2C+S&amp;rft.au=Ma%2C+L&amp;rft.au=Wheeler%2C+A&amp;rft.au=Chen%2C+Y&amp;rft.au=Zhang%2C+Y&amp;rft.au=Liu%2C+B&amp;rft.au=Xiong%2C+J&amp;rft.au=Zhang%2C+W&amp;rft.au=Hu%2C+J&amp;rft.au=Zhou%2C+Z&amp;rft.au=Dong%2C+B&amp;rft.au=Tian%2C+Z&amp;rft.au=Jeffrey%2C+SS&amp;rft.au=Chua%2C+MS&amp;rft.au=So%2C+S&amp;rft.au=Li%2C+W&amp;rft.au=Wei%2C+Y&amp;rft.au=Diao%2C+J&amp;rft.au=Xie%2C+D&amp;rft.au=Quake%2C+SR&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5630676&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:2-22\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:2_22-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:2_22-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:2_22-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:2_22-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:2_22-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-:2_22-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Butler TM, Spellman PT, Gray J (February 2017). <span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.sciencedirect.com/science/article/pii/S0959437X17300011\">\"Circulating-tumor DNA as an early detection and diagnostic tool\"<span style=\"padding-left:0.15em\"><img alt=\"Paid subscription required\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/9px-Lock-red-alt.svg.png\" title=\"Paid subscription required\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/14px-Lock-red-alt.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Lock-red-alt.svg/18px-Lock-red-alt.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span></a></span>. <i>Current Opinion in Genetics &amp; Development</i>. <b>42</b>: 14\u201321. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.gde.2016.12.003\">10.1016/j.gde.2016.12.003</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28126649\">28126649</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Genetics+%26+Development&amp;rft.atitle=Circulating-tumor+DNA+as+an+early+detection+and+diagnostic+tool&amp;rft.volume=42&amp;rft.pages=14-21&amp;rft.date=2017-02&amp;rft_id=info%3Adoi%2F10.1016%2Fj.gde.2016.12.003&amp;rft_id=info%3Apmid%2F28126649&amp;rft.aulast=Butler&amp;rft.aufirst=TM&amp;rft.au=Spellman%2C+PT&amp;rft.au=Gray%2C+J&amp;rft_id=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0959437X17300011&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dressman D, Yan H, Traverso G, Kinzler KW, Vogelstein B (July 2003). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC166396\">\"Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations\"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>100</b> (15): 8817\u201322. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.1133470100\">10.1073/pnas.1133470100</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC166396\">166396</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12857956\">12857956</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Transforming+single+DNA+molecules+into+fluorescent+magnetic+particles+for+detection+and+enumeration+of+genetic+variations&amp;rft.volume=100&amp;rft.issue=15&amp;rft.pages=8817-22&amp;rft.date=2003-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC166396&amp;rft_id=info%3Apmid%2F12857956&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.1133470100&amp;rft.aulast=Dressman&amp;rft.aufirst=D&amp;rft.au=Yan%2C+H&amp;rft.au=Traverso%2C+G&amp;rft.au=Kinzler%2C+KW&amp;rft.au=Vogelstein%2C+B&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC166396&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Diehl F, Li M, He Y, Kinzler KW, Vogelstein B, Dressman D (July 2006). \"BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions\". <i>Nature Methods</i>. <b>3</b> (7): 551\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nmeth898\">10.1038/nmeth898</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16791214\">16791214</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Methods&amp;rft.atitle=BEAMing%3A+single-molecule+PCR+on+microparticles+in+water-in-oil+emulsions&amp;rft.volume=3&amp;rft.issue=7&amp;rft.pages=551-9&amp;rft.date=2006-07&amp;rft_id=info%3Adoi%2F10.1038%2Fnmeth898&amp;rft_id=info%3Apmid%2F16791214&amp;rft.aulast=Diehl&amp;rft.aufirst=F&amp;rft.au=Li%2C+M&amp;rft.au=He%2C+Y&amp;rft.au=Kinzler%2C+KW&amp;rft.au=Vogelstein%2C+B&amp;rft.au=Dressman%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW, Alizadeh AA, Diehn M (May 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4016134\">\"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage\"</a>. <i>Nature Medicine</i>. <b>20</b> (5): 548\u201354. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nm.3519\">10.1038/nm.3519</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4016134\">4016134</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24705333\">24705333</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Medicine&amp;rft.atitle=An+ultrasensitive+method+for+quantitating+circulating+tumor+DNA+with+broad+patient+coverage&amp;rft.volume=20&amp;rft.issue=5&amp;rft.pages=548-54&amp;rft.date=2014-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4016134&amp;rft_id=info%3Apmid%2F24705333&amp;rft_id=info%3Adoi%2F10.1038%2Fnm.3519&amp;rft.aulast=Newman&amp;rft.aufirst=AM&amp;rft.au=Bratman%2C+SV&amp;rft.au=To%2C+J&amp;rft.au=Wynne%2C+JF&amp;rft.au=Eclov%2C+NC&amp;rft.au=Modlin%2C+LA&amp;rft.au=Liu%2C+CL&amp;rft.au=Neal%2C+JW&amp;rft.au=Wakelee%2C+HA&amp;rft.au=Merritt%2C+RE&amp;rft.au=Shrager%2C+JB&amp;rft.au=Loo%2C+BW&amp;rft.au=Alizadeh%2C+AA&amp;rft.au=Diehn%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4016134&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Newman_2016-26\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Newman_2016_26-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Newman_2016_26-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F,  et al. (May 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4907374\">\"Integrated digital error suppression for improved detection of circulating tumor DNA\"</a>. <i>Nature Biotechnology</i>. <b>34</b> (5): 547\u2013555. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nbt.3520\">10.1038/nbt.3520</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4907374\">4907374</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27018799\">27018799</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Biotechnology&amp;rft.atitle=Integrated+digital+error+suppression+for+improved+detection+of+circulating+tumor+DNA&amp;rft.volume=34&amp;rft.issue=5&amp;rft.pages=547-555&amp;rft.date=2016-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4907374&amp;rft_id=info%3Apmid%2F27018799&amp;rft_id=info%3Adoi%2F10.1038%2Fnbt.3520&amp;rft.aulast=Newman&amp;rft.aufirst=AM&amp;rft.au=Lovejoy%2C+AF&amp;rft.au=Klass%2C+DM&amp;rft.au=Kurtz%2C+DM&amp;rft.au=Chabon%2C+JJ&amp;rft.au=Scherer%2C+F&amp;rft.au=Stehr%2C+H&amp;rft.au=Liu%2C+CL&amp;rft.au=Bratman%2C+SV&amp;rft.au=Say%2C+C&amp;rft.au=Zhou%2C+L&amp;rft.au=Carter%2C+JN&amp;rft.au=West%2C+RB&amp;rft.au=Sledge%2C+GW&amp;rft.au=Shrager%2C+JB&amp;rft.au=Loo%2C+BW&amp;rft.au=Neal%2C+JW&amp;rft.au=Wakelee%2C+HA&amp;rft.au=Diehn%2C+M&amp;rft.au=Alizadeh%2C+AA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4907374&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, Dawson SJ, Piskorz AM, Jimenez-Linan M, Bentley D, Hadfield J, May AP, Caldas C, Brenton JD, Rosenfeld N (May 2012). \"Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA\". <i>Science Translational Medicine</i>. <b>4</b> (136): 136ra68. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/scitranslmed.3003726\">10.1126/scitranslmed.3003726</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22649089\">22649089</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science+Translational+Medicine&amp;rft.atitle=Noninvasive+identification+and+monitoring+of+cancer+mutations+by+targeted+deep+sequencing+of+plasma+DNA&amp;rft.volume=4&amp;rft.issue=136&amp;rft.pages=136ra68&amp;rft.date=2012-05&amp;rft_id=info%3Adoi%2F10.1126%2Fscitranslmed.3003726&amp;rft_id=info%3Apmid%2F22649089&amp;rft.aulast=Forshew&amp;rft.aufirst=T&amp;rft.au=Murtaza%2C+M&amp;rft.au=Parkinson%2C+C&amp;rft.au=Gale%2C+D&amp;rft.au=Tsui%2C+DW&amp;rft.au=Kaper%2C+F&amp;rft.au=Dawson%2C+SJ&amp;rft.au=Piskorz%2C+AM&amp;rft.au=Jimenez-Linan%2C+M&amp;rft.au=Bentley%2C+D&amp;rft.au=Hadfield%2C+J&amp;rft.au=May%2C+AP&amp;rft.au=Caldas%2C+C&amp;rft.au=Brenton%2C+JD&amp;rft.au=Rosenfeld%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kinde I, Wu J, Papadopoulos N, Kinzler KW, Vogelstein B (June 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3111315\">\"Detection and quantification of rare mutations with massively parallel sequencing\"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>108</b> (23): 9530\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.1105422108\">10.1073/pnas.1105422108</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3111315\">3111315</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21586637\">21586637</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Detection+and+quantification+of+rare+mutations+with+massively+parallel+sequencing&amp;rft.volume=108&amp;rft.issue=23&amp;rft.pages=9530-5&amp;rft.date=2011-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3111315&amp;rft_id=info%3Apmid%2F21586637&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.1105422108&amp;rft.aulast=Kinde&amp;rft.aufirst=I&amp;rft.au=Wu%2C+J&amp;rft.au=Papadopoulos%2C+N&amp;rft.au=Kinzler%2C+KW&amp;rft.au=Vogelstein%2C+B&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3111315&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kennedy SR, Schmitt MW, Fox EJ, Kohrn BF, Salk JJ, Ahn EH, Prindle MJ, Kuong KJ, Shen JC, Risques RA, Loeb LA (November 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4271547\">\"Detecting ultralow-frequency mutations by Duplex Sequencing\"</a>. <i>Nature Protocols</i>. <b>9</b> (11): 2586\u2013606. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nprot.2014.170\">10.1038/nprot.2014.170</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4271547\">4271547</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25299156\">25299156</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Protocols&amp;rft.atitle=Detecting+ultralow-frequency+mutations+by+Duplex+Sequencing&amp;rft.volume=9&amp;rft.issue=11&amp;rft.pages=2586-606&amp;rft.date=2014-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4271547&amp;rft_id=info%3Apmid%2F25299156&amp;rft_id=info%3Adoi%2F10.1038%2Fnprot.2014.170&amp;rft.aulast=Kennedy&amp;rft.aufirst=SR&amp;rft.au=Schmitt%2C+MW&amp;rft.au=Fox%2C+EJ&amp;rft.au=Kohrn%2C+BF&amp;rft.au=Salk%2C+JJ&amp;rft.au=Ahn%2C+EH&amp;rft.au=Prindle%2C+MJ&amp;rft.au=Kuong%2C+KJ&amp;rft.au=Shen%2C+JC&amp;rft.au=Risques%2C+RA&amp;rft.au=Loeb%2C+LA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4271547&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rapisuwon S, Vietsch EE, Wellstein A (2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4913179\">\"Circulating biomarkers to monitor cancer progression and treatment\"</a>. <i>Computational and Structural Biotechnology Journal</i>. <b>14</b>: 211\u201322. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.csbj.2016.05.004\">10.1016/j.csbj.2016.05.004</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4913179\">4913179</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27358717\">27358717</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Computational+and+Structural+Biotechnology+Journal&amp;rft.atitle=Circulating+biomarkers+to+monitor+cancer+progression+and+treatment&amp;rft.volume=14&amp;rft.pages=211-22&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4913179&amp;rft_id=info%3Apmid%2F27358717&amp;rft_id=info%3Adoi%2F10.1016%2Fj.csbj.2016.05.004&amp;rft.aulast=Rapisuwon&amp;rft.aufirst=S&amp;rft.au=Vietsch%2C+EE&amp;rft.au=Wellstein%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4913179&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:4-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-:4_31-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Crowley E, Di Nicolantonio F, Loupakis F, Bardelli A (August 2013). \"Liquid biopsy: monitoring cancer-genetics in the blood\". <i>Nature Reviews. Clinical Oncology</i>. <b>10</b> (8): 472\u201384. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrclinonc.2013.110\">10.1038/nrclinonc.2013.110</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23836314\">23836314</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Clinical+Oncology&amp;rft.atitle=Liquid+biopsy%3A+monitoring+cancer-genetics+in+the+blood&amp;rft.volume=10&amp;rft.issue=8&amp;rft.pages=472-84&amp;rft.date=2013-08&amp;rft_id=info%3Adoi%2F10.1038%2Fnrclinonc.2013.110&amp;rft_id=info%3Apmid%2F23836314&amp;rft.aulast=Crowley&amp;rft.aufirst=E&amp;rft.au=Di+Nicolantonio%2C+F&amp;rft.au=Loupakis%2C+F&amp;rft.au=Bardelli%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, Chin SF, Tsui DW, Marass F, Gale D, Ali HR, Shah P, Contente-Cuomo T, Farahani H, Shumansky K, Kingsbury Z, Humphray S, Bentley D, Shah SP, Wallis M, Rosenfeld N, Caldas C (November 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4659935\">\"Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer\"</a>. <i>Nature Communications</i>. <b>6</b>: 8760. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/ncomms9760\">10.1038/ncomms9760</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4659935\">4659935</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26530965\">26530965</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Communications&amp;rft.atitle=Multifocal+clonal+evolution+characterized+using+circulating+tumour+DNA+in+a+case+of+metastatic+breast+cancer&amp;rft.volume=6&amp;rft.pages=8760&amp;rft.date=2015-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4659935&amp;rft_id=info%3Apmid%2F26530965&amp;rft_id=info%3Adoi%2F10.1038%2Fncomms9760&amp;rft.aulast=Murtaza&amp;rft.aufirst=M&amp;rft.au=Dawson%2C+SJ&amp;rft.au=Pogrebniak%2C+K&amp;rft.au=Rueda%2C+OM&amp;rft.au=Provenzano%2C+E&amp;rft.au=Grant%2C+J&amp;rft.au=Chin%2C+SF&amp;rft.au=Tsui%2C+DW&amp;rft.au=Marass%2C+F&amp;rft.au=Gale%2C+D&amp;rft.au=Ali%2C+HR&amp;rft.au=Shah%2C+P&amp;rft.au=Contente-Cuomo%2C+T&amp;rft.au=Farahani%2C+H&amp;rft.au=Shumansky%2C+K&amp;rft.au=Kingsbury%2C+Z&amp;rft.au=Humphray%2C+S&amp;rft.au=Bentley%2C+D&amp;rft.au=Shah%2C+SP&amp;rft.au=Wallis%2C+M&amp;rft.au=Rosenfeld%2C+N&amp;rft.au=Caldas%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4659935&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Circulating_tumor_DNA&amp;action=edit&amp;section=27\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genome.gov/27556716\">Circulating tumor DNA: A new generation of cancer biomarkers</a> Feb 2014</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.medscape.com/viewarticle/835140\">ctDNA 'Liquid Biopsy' Could Revolutionize Cancer Care</a> Nov 2014</li>\n<li><cite class=\"citation journal\">Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW, Alizadeh AA, Diehn M (May 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4016134\">\"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage\"</a>. <i>Nature Medicine</i>. <b>20</b> (5): 548\u201354. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nm.3519\">10.1038/nm.3519</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4016134\">4016134</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24705333\">24705333</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Medicine&amp;rft.atitle=An+ultrasensitive+method+for+quantitating+circulating+tumor+DNA+with+broad+patient+coverage&amp;rft.volume=20&amp;rft.issue=5&amp;rft.pages=548-54&amp;rft.date=2014-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4016134&amp;rft_id=info%3Apmid%2F24705333&amp;rft_id=info%3Adoi%2F10.1038%2Fnm.3519&amp;rft.aulast=Newman&amp;rft.aufirst=AM&amp;rft.au=Bratman%2C+SV&amp;rft.au=To%2C+J&amp;rft.au=Wynne%2C+JF&amp;rft.au=Eclov%2C+NC&amp;rft.au=Modlin%2C+LA&amp;rft.au=Liu%2C+CL&amp;rft.au=Neal%2C+JW&amp;rft.au=Wakelee%2C+HA&amp;rft.au=Merritt%2C+RE&amp;rft.au=Shrager%2C+JB&amp;rft.au=Loo%2C+BW&amp;rft.au=Alizadeh%2C+AA&amp;rft.au=Diehn%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4016134&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Karachaliou N, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R (March 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4356857\">\"Real-time liquid biopsies become a reality in cancer treatment\"</a>. <i>Annals of Translational Medicine</i>. <b>3</b> (3): 36. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3978/j.issn.2305-5839.2015.01.16\">10.3978/j.issn.2305-5839.2015.01.16</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4356857\">4356857</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25815297\">25815297</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Translational+Medicine&amp;rft.atitle=Real-time+liquid+biopsies+become+a+reality+in+cancer+treatment&amp;rft.volume=3&amp;rft.issue=3&amp;rft.pages=36&amp;rft.date=2015-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4356857&amp;rft_id=info%3Apmid%2F25815297&amp;rft_id=info%3Adoi%2F10.3978%2Fj.issn.2305-5839.2015.01.16&amp;rft.aulast=Karachaliou&amp;rft.aufirst=N&amp;rft.au=Mayo-de-Las-Casas%2C+C&amp;rft.au=Molina-Vila%2C+MA&amp;rft.au=Rosell%2C+R&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4356857&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation news\">Marusina, Kate (8 February 2018). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.clinicalomics.com/articles/teasing-out-circulating-tumor-dna/1491\">\"Teasing Out Circulating Tumor DNA\"</a>. <i>ClinicalOMICs</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">5 March</span> 2018</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ClinicalOMICs&amp;rft.atitle=Teasing+Out+Circulating+Tumor+DNA&amp;rft.date=2018-02-08&amp;rft.aulast=Marusina&amp;rft.aufirst=Kate&amp;rft_id=https%3A%2F%2Fwww.clinicalomics.com%2Farticles%2Fteasing-out-circulating-tumor-dna%2F1491&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACirculating+tumor+DNA\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Pathology\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Pathology\" title=\"Template:Pathology\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Pathology\" title=\"Template talk:Pathology\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Pathology&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Pathology\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Pathology\" title=\"Pathology\">Pathology</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Principles of pathology</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><b><a href=\"/wiki/Disease\" title=\"Disease\">Disease</a></b>\n<ul><li><b><a href=\"/wiki/Infection\" title=\"Infection\">Infection</a></b></li>\n<li><b><a href=\"/wiki/Neoplasia\" class=\"mw-redirect\" title=\"Neoplasia\">Neoplasia</a></b></li>\n<li><b><a href=\"/wiki/Cause_(medicine)\" title=\"Cause (medicine)\">Cause</a></b></li>\n<li><b><a href=\"/wiki/Pathogenesis\" title=\"Pathogenesis\">Pathogenesis</a></b></li></ul></li>\n<li><b><a href=\"/wiki/Hemodynamics\" title=\"Hemodynamics\">Hemodynamics</a></b>\n<ul><li><b><a href=\"/wiki/Ischemia\" title=\"Ischemia\">Ischemia</a></b></li></ul></li>\n<li><b><a href=\"/wiki/Inflammation\" title=\"Inflammation\">Inflammation</a></b></li>\n<li><b><a href=\"/wiki/Cell_damage\" title=\"Cell damage\">Cell damage</a></b></li>\n<li><b><a href=\"/wiki/Wound_healing\" title=\"Wound healing\">Wound healing</a></b></li></ul>\n<dl><dt><a href=\"/wiki/Cellular_adaptation\" title=\"Cellular adaptation\">Cellular adaptation</a></dt>\n<dd></dd>\n<dd><a href=\"/wiki/Atrophy\" title=\"Atrophy\">Atrophy</a></dd>\n<dd><a href=\"/wiki/Hypertrophy\" title=\"Hypertrophy\">Hypertrophy</a></dd>\n<dd><a href=\"/wiki/Hyperplasia\" title=\"Hyperplasia\">Hyperplasia</a></dd>\n<dd><a href=\"/wiki/Dysplasia\" title=\"Dysplasia\">Dysplasia</a></dd>\n<dd><a href=\"/wiki/Metaplasia\" title=\"Metaplasia\">Metaplasia</a>\n<dl><dd><a href=\"/wiki/Squamous_metaplasia\" title=\"Squamous metaplasia\">Squamous</a></dd>\n<dd><a href=\"/wiki/Glandular_metaplasia\" title=\"Glandular metaplasia\">Glandular</a></dd></dl></dd></dl>\n<dl><dt><a href=\"/wiki/Cell_death\" title=\"Cell death\">Cell death</a></dt>\n<dd></dd>\n<dd><a href=\"/wiki/Necrosis\" title=\"Necrosis\">Necrosis</a>\n<dl><dd><a href=\"/wiki/Coagulative_necrosis\" title=\"Coagulative necrosis\">Coagulative necrosis</a></dd>\n<dd><a href=\"/wiki/Liquefactive_necrosis\" title=\"Liquefactive necrosis\">Liquefactive necrosis</a></dd>\n<dd><a href=\"/wiki/Gangrene\" title=\"Gangrene\">Gangrenous necrosis</a></dd>\n<dd><a href=\"/wiki/Caseous_necrosis\" title=\"Caseous necrosis\">Caseous necrosis</a></dd>\n<dd><a href=\"/wiki/Fat_necrosis\" title=\"Fat necrosis\">Fat necrosis</a></dd>\n<dd><a href=\"/wiki/Fibrinoid_necrosis\" title=\"Fibrinoid necrosis\">Fibrinoid necrosis</a></dd></dl></dd>\n<dd><a href=\"/wiki/Programmed_cell_death\" title=\"Programmed cell death\">Programmed cell death</a>\n<dl><dd><a href=\"/wiki/Apoptosis\" title=\"Apoptosis\">Apoptosis</a></dd></dl></dd>\n<dd><a href=\"/wiki/Pyknosis\" title=\"Pyknosis\">Pyknosis</a></dd>\n<dd><a href=\"/wiki/Karyorrhexis\" title=\"Karyorrhexis\">Karyorrhexis</a></dd>\n<dd><a href=\"/wiki/Karyolysis\" title=\"Karyolysis\">Karyolysis</a></dd></dl>\n<dl><dt><i>Accumulations</i></dt>\n<dd><i><a href=\"/wiki/Pigment\" title=\"Pigment\">pigment</a></i>\n<dl><dd><a href=\"/wiki/Hemosiderin\" title=\"Hemosiderin\">Hemosiderin</a></dd>\n<dd><a href=\"/wiki/Lipochrome\" title=\"Lipochrome\">Lipochrome</a>/<a href=\"/wiki/Lipofuscin\" title=\"Lipofuscin\">Lipofuscin</a></dd>\n<dd><a href=\"/wiki/Melanin\" title=\"Melanin\">Melanin</a></dd></dl></dd>\n<dd><a href=\"/wiki/Steatosis\" title=\"Steatosis\">Steatosis</a></dd></dl>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Anatomical_pathology\" title=\"Anatomical pathology\">Anatomical pathology</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><b><a href=\"/wiki/Surgical_pathology\" title=\"Surgical pathology\">Surgical pathology</a></b></li>\n<li><b><a href=\"/wiki/Cytopathology\" title=\"Cytopathology\">Cytopathology</a></b></li>\n<li><b><a href=\"/wiki/Autopsy\" title=\"Autopsy\">Autopsy</a></b></li>\n<li><b><a href=\"/wiki/Molecular_pathology\" title=\"Molecular pathology\">Molecular pathology</a></b></li>\n<li><b><a href=\"/wiki/Forensic_pathology\" title=\"Forensic pathology\">Forensic pathology</a></b></li>\n<li><b><a href=\"/wiki/Oral_and_maxillofacial_pathology\" title=\"Oral and maxillofacial pathology\">Oral and maxillofacial pathology</a></b></li></ul>\n<ul><li><a href=\"/wiki/Gross_examination\" title=\"Gross examination\">Gross examination</a></li>\n<li><a href=\"/wiki/Histopathology\" title=\"Histopathology\">Histopathology</a></li>\n<li><a href=\"/wiki/Immunohistochemistry\" title=\"Immunohistochemistry\">Immunohistochemistry</a></li>\n<li><a href=\"/wiki/Electron_microscopy\" class=\"mw-redirect\" title=\"Electron microscopy\">Electron microscopy</a></li>\n<li><a href=\"/wiki/Immunofluorescence\" title=\"Immunofluorescence\">Immunofluorescence</a></li>\n<li><a href=\"/wiki/Fluorescence_in_situ_hybridization\" title=\"Fluorescence in situ hybridization\">Fluorescence in situ hybridization</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Clinical_pathology\" title=\"Clinical pathology\">Clinical pathology</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><b><a href=\"/wiki/Clinical_chemistry\" title=\"Clinical chemistry\">Clinical chemistry</a></b></li>\n<li><b><a href=\"/wiki/Hematopathology\" title=\"Hematopathology\">Hematopathology</a></b></li>\n<li><b><a href=\"/wiki/Transfusion_medicine\" title=\"Transfusion medicine\">Transfusion medicine</a></b></li>\n<li><b><a href=\"/wiki/Medical_microbiology\" title=\"Medical microbiology\">Medical microbiology</a></b></li>\n<li><b><a href=\"/wiki/Diagnostic_immunology\" class=\"mw-redirect\" title=\"Diagnostic immunology\">Diagnostic immunology</a></b></li>\n<li><b><a href=\"/wiki/Immunopathology\" title=\"Immunopathology\">Immunopathology</a></b></li></ul>\n<ul><li><a href=\"/wiki/Enzyme_assay\" title=\"Enzyme assay\">Enzyme assay</a></li>\n<li><a href=\"/wiki/Mass_spectrometry\" title=\"Mass spectrometry\">Mass spectrometry</a></li>\n<li><a href=\"/wiki/Chromatography\" title=\"Chromatography\">Chromatography</a></li>\n<li><a href=\"/wiki/Flow_cytometry\" title=\"Flow cytometry\">Flow cytometry</a></li>\n<li><a href=\"/wiki/Blood_bank\" title=\"Blood bank\">Blood bank</a></li>\n<li><a href=\"/wiki/Microbiological_culture\" title=\"Microbiological culture\">Microbiological culture</a></li>\n<li><a href=\"/wiki/Serology\" title=\"Serology\">Serology</a></li></ul>\n</div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Overview_of_tumors,_cancer_and_oncology_(C00\u2013D48,_140\u2013239)\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Tumors\" title=\"Template:Tumors\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Tumors\" title=\"Template talk:Tumors\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Tumors&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Overview_of_tumors,_cancer_and_oncology_(C00\u2013D48,_140\u2013239)\" style=\"font-size:114%;margin:0 4em\">Overview of <a href=\"/wiki/Neoplasm\" title=\"Neoplasm\">tumors</a>, <a href=\"/wiki/Cancer\" title=\"Cancer\">cancer</a> and <a href=\"/wiki/Oncology\" title=\"Oncology\">oncology</a> (<a href=\"/wiki/ICD-10_Chapter_II:_Neoplasms\" title=\"ICD-10 Chapter II: Neoplasms\">C00\u2013D48</a>, <a href=\"/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms\" title=\"List of ICD-9 codes 140\u2013239: neoplasms\">140\u2013239</a>)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Conditions</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Benign_tumor\" title=\"Benign tumor\">Benign tumors</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Hyperplasia\" title=\"Hyperplasia\">Hyperplasia</a></li>\n<li><a href=\"/wiki/Cyst\" title=\"Cyst\">Cyst</a></li>\n<li><a href=\"/wiki/Pseudocyst\" title=\"Pseudocyst\">Pseudocyst</a></li>\n<li><a href=\"/wiki/Hamartoma\" title=\"Hamartoma\">Hamartoma</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Malignant progression</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Dysplasia\" title=\"Dysplasia\">Dysplasia</a></li>\n<li><a href=\"/wiki/Carcinoma_in_situ\" title=\"Carcinoma in situ\">Carcinoma in situ</a></li>\n<li><a href=\"/wiki/Cancer\" title=\"Cancer\">Cancer</a></li>\n<li><a href=\"/wiki/Metastasis\" title=\"Metastasis\">Metastasis</a></li>\n<li><a href=\"/wiki/Primary_tumor\" title=\"Primary tumor\">Primary tumor</a></li>\n<li><a href=\"/wiki/Sentinel_lymph_node\" title=\"Sentinel lymph node\">Sentinel lymph node</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Topography</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Head_and_neck_cancer\" title=\"Head and neck cancer\">Head/Neck</a> (<a href=\"/wiki/Oral_cancer\" title=\"Oral cancer\">Oral</a>, <a href=\"/wiki/Nasopharynx_cancer\" title=\"Nasopharynx cancer\">Nasopharyngeal</a>)</li>\n<li><a href=\"/wiki/Digestive_system_neoplasm\" title=\"Digestive system neoplasm\">Digestive system</a></li>\n<li><a href=\"/wiki/Neoplasm\" title=\"Neoplasm\">Respiratory system</a></li>\n<li><a href=\"/wiki/Bone_tumor\" title=\"Bone tumor\">Bone</a></li>\n<li><a href=\"/wiki/Skin_cancer\" title=\"Skin cancer\">Skin</a></li>\n<li><a href=\"/wiki/Leukemia\" title=\"Leukemia\">Blood</a></li>\n<li><a href=\"/wiki/Urogenital_neoplasm\" title=\"Urogenital neoplasm\">Urogenital</a></li>\n<li><a href=\"/wiki/Nervous_system_neoplasm\" title=\"Nervous system neoplasm\">Nervous system</a></li>\n<li><a href=\"/wiki/Endocrine_gland_neoplasm\" title=\"Endocrine gland neoplasm\">Endocrine system</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Histology</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Carcinoma\" title=\"Carcinoma\">Carcinoma</a></li>\n<li><a href=\"/wiki/Sarcoma\" title=\"Sarcoma\">Sarcoma</a></li>\n<li><a href=\"/wiki/Blastoma\" title=\"Blastoma\">Blastoma</a></li>\n<li><a href=\"/wiki/Papilloma\" title=\"Papilloma\">Papilloma</a></li>\n<li><a href=\"/wiki/Adenoma\" title=\"Adenoma\">Adenoma</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Precancerous_condition\" title=\"Precancerous condition\">Precancerous condition</a></li>\n<li><a href=\"/wiki/Paraneoplastic_syndrome\" title=\"Paraneoplastic syndrome\">Paraneoplastic syndrome</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Cancer_staging\" title=\"Cancer staging\">Staging</a>/<a href=\"/wiki/Grading_(tumors)\" title=\"Grading (tumors)\">grading</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/TNM_staging_system\" title=\"TNM staging system\">TNM</a></li>\n<li><a href=\"/wiki/Ann_Arbor_staging\" title=\"Ann Arbor staging\">Ann Arbor</a></li>\n<li><a href=\"/wiki/Prostate_cancer_staging\" title=\"Prostate cancer staging\">Prostate cancer staging</a></li>\n<li><a href=\"/wiki/Gleason_grading_system\" title=\"Gleason grading system\">Gleason grading system</a></li>\n<li><a href=\"/wiki/Dukes_classification\" class=\"mw-redirect\" title=\"Dukes classification\">Dukes classification</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Carcinogenesis\" title=\"Carcinogenesis\">Carcinogenesis</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Cancer_cell\" title=\"Cancer cell\">Cancer cell</a></li>\n<li><a href=\"/wiki/Carcinogen\" title=\"Carcinogen\">Carcinogen</a></li>\n<li><a href=\"/wiki/Tumor_suppressor_gene\" class=\"mw-redirect\" title=\"Tumor suppressor gene\">Tumor suppressor genes</a>/<a href=\"/wiki/Oncogene\" title=\"Oncogene\">oncogenes</a></li>\n<li><a href=\"/wiki/Clonally_transmissible_cancer\" title=\"Clonally transmissible cancer\">Clonally transmissible cancer</a></li>\n<li><a href=\"/wiki/Oncovirus\" title=\"Oncovirus\">Oncovirus</a></li>\n<li><a href=\"/wiki/Carcinogenic_bacteria\" title=\"Carcinogenic bacteria\">Carcinogenic bacteria</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Misc.</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Cancer_research\" title=\"Cancer research\">Research</a></li>\n<li><a href=\"/wiki/Index_of_oncology_articles\" title=\"Index of oncology articles\">Index of oncology articles</a></li>\n<li><a href=\"/wiki/History_of_cancer\" title=\"History of cancer\">History</a></li>\n<li><a href=\"/wiki/Cancer_pain\" title=\"Cancer pain\">Cancer pain</a></li>\n<li><a href=\"/wiki/Cancer_and_nausea\" title=\"Cancer and nausea\">Cancer and nausea</a></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2240\nCached time: 20180920082519\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.460 seconds\nReal time usage: 0.490 seconds\nPreprocessor visited node count: 1786/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 124334/2097152 bytes\nTemplate argument size: 85/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 67431/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.253/10.000 seconds\nLua memory usage: 3.13 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  359.325      1 -total\n 88.46%  317.874      1 Template:Reflist\n 74.56%  267.919     34 Template:Cite_journal\n  5.50%   19.762      3 Template:Navbox\n  4.11%   14.777      1 Template:Pathology\n  2.16%    7.750      1 Template:Tumors\n  1.50%    5.407      1 Template:Cite_news\n  0.48%    1.709      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:44690654-0!canonical and timestamp 20180920082518 and revision id 860380729\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"CS1_Russian-language_sources_(ru)"},{"sortkey":"","*":"Anatomical_pathology"},{"sortkey":"","*":"Medical_signs"},{"sortkey":"","*":"Oncology"},{"sortkey":"","*":"Surgical_removal_procedures"},{"sortkey":"","*":"Neoplasms"},{"sortkey":"","*":"DNA"}],"links":[{"ns":10,"exists":"","*":"Template:Pathology"},{"ns":10,"exists":"","*":"Template:Tumors"},{"ns":0,"exists":"","*":"Adenoma"},{"ns":0,"exists":"","*":"Anatomical pathology"},{"ns":0,"exists":"","*":"Ann Arbor staging"},{"ns":0,"exists":"","*":"Apoptosis"},{"ns":0,"exists":"","*":"Apoptotic DNA fragmentation"},{"ns":0,"exists":"","*":"Atrophy"},{"ns":0,"exists":"","*":"Autopsy"},{"ns":0,"exists":"","*":"BEAMing"},{"ns":0,"exists":"","*":"Benign tumor"},{"ns":0,"exists":"","*":"Bisulfite sequencing"},{"ns":0,"exists":"","*":"Blastoma"},{"ns":0,"exists":"","*":"Blood"},{"ns":0,"exists":"","*":"Blood bank"},{"ns":0,"exists":"","*":"Blood plasma"},{"ns":0,"exists":"","*":"Bone tumor"},{"ns":0,"exists":"","*":"Buccal swab"},{"ns":0,"exists":"","*":"CAPP-Seq"},{"ns":0,"exists":"","*":"CT scan"},{"ns":0,"exists":"","*":"Cancer"},{"ns":0,"exists":"","*":"Cancer and nausea"},{"ns":0,"exists":"","*":"Cancer cell"},{"ns":0,"exists":"","*":"Cancer pain"},{"ns":0,"exists":"","*":"Cancer research"},{"ns":0,"exists":"","*":"Cancer staging"},{"ns":0,"exists":"","*":"Carcinogen"},{"ns":0,"exists":"","*":"Carcinogenesis"},{"ns":0,"exists":"","*":"Carcinogenic bacteria"},{"ns":0,"exists":"","*":"Carcinoma"},{"ns":0,"exists":"","*":"Carcinoma in situ"},{"ns":0,"exists":"","*":"Caseous necrosis"},{"ns":0,"exists":"","*":"Cause (medicine)"},{"ns":0,"exists":"","*":"Cell damage"},{"ns":0,"exists":"","*":"Cell death"},{"ns":0,"exists":"","*":"Cellular adaptation"},{"ns":0,"exists":"","*":"Chemotherapy"},{"ns":0,"exists":"","*":"Chromatography"},{"ns":0,"exists":"","*":"Circulating mitochondrial DNA"},{"ns":0,"exists":"","*":"Circulating tumor cell"},{"ns":0,"exists":"","*":"Clinical chemistry"},{"ns":0,"exists":"","*":"Clinical pathology"},{"ns":0,"exists":"","*":"Clonally transmissible cancer"},{"ns":0,"exists":"","*":"Coagulative necrosis"},{"ns":0,"exists":"","*":"Copy-number variation"},{"ns":0,"exists":"","*":"CpG islands"},{"ns":0,"exists":"","*":"Cyst"},{"ns":0,"exists":"","*":"Cytopathology"},{"ns":0,"exists":"","*":"DNA"},{"ns":0,"exists":"","*":"DNA methylation"},{"ns":0,"exists":"","*":"Diagnostic immunology"},{"ns":0,"exists":"","*":"Digestive system neoplasm"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Digital polymerase chain reaction"},{"ns":0,"exists":"","*":"Disease"},{"ns":0,"exists":"","*":"Dukes classification"},{"ns":0,"exists":"","*":"Duplex sequencing"},{"ns":0,"exists":"","*":"Dysplasia"},{"ns":0,"exists":"","*":"Edta"},{"ns":0,"exists":"","*":"Electron microscopy"},{"ns":0,"exists":"","*":"Endocrine gland neoplasm"},{"ns":0,"exists":"","*":"Enzyme assay"},{"ns":0,"exists":"","*":"Epigenetics"},{"ns":0,"exists":"","*":"Fat necrosis"},{"ns":0,"exists":"","*":"Fibrinoid necrosis"},{"ns":0,"exists":"","*":"Flow cytometry"},{"ns":0,"exists":"","*":"Fluorescence in situ hybridization"},{"ns":0,"exists":"","*":"Forensic pathology"},{"ns":0,"exists":"","*":"Gangrene"},{"ns":0,"exists":"","*":"Genome"},{"ns":0,"exists":"","*":"Glandular metaplasia"},{"ns":0,"exists":"","*":"Gleason grading system"},{"ns":0,"exists":"","*":"Grading (tumors)"},{"ns":0,"exists":"","*":"Gross examination"},{"ns":0,"exists":"","*":"Hamartoma"},{"ns":0,"exists":"","*":"Head and neck cancer"},{"ns":0,"exists":"","*":"Hematopathology"},{"ns":0,"exists":"","*":"Hemodynamics"},{"ns":0,"exists":"","*":"Hemosiderin"},{"ns":0,"exists":"","*":"High throughput sequencing"},{"ns":0,"exists":"","*":"Histopathology"},{"ns":0,"exists":"","*":"History of cancer"},{"ns":0,"exists":"","*":"Hyperplasia"},{"ns":0,"exists":"","*":"Hypertrophy"},{"ns":0,"exists":"","*":"ICD-10 Chapter II: Neoplasms"},{"ns":0,"exists":"","*":"Immunofluorescence"},{"ns":0,"exists":"","*":"Immunohistochemistry"},{"ns":0,"exists":"","*":"Immunopathology"},{"ns":0,"exists":"","*":"Index of oncology articles"},{"ns":0,"exists":"","*":"Infection"},{"ns":0,"exists":"","*":"Inflammation"},{"ns":0,"exists":"","*":"Ischemia"},{"ns":0,"exists":"","*":"Karyolysis"},{"ns":0,"exists":"","*":"Karyorrhexis"},{"ns":0,"exists":"","*":"Karyotype"},{"ns":0,"exists":"","*":"Leukemia"},{"ns":0,"exists":"","*":"Lipochrome"},{"ns":0,"exists":"","*":"Lipofuscin"},{"ns":0,"exists":"","*":"Liquefactive necrosis"},{"ns":0,"exists":"","*":"Liquid biopsy"},{"ns":0,"exists":"","*":"List of ICD-9 codes 140\u2013239: neoplasms"},{"ns":0,"exists":"","*":"Lymphatic"},{"ns":0,"exists":"","*":"Magnetic resonance imaging"},{"ns":0,"exists":"","*":"Mass spectrometry"},{"ns":0,"exists":"","*":"Medical microbiology"},{"ns":0,"exists":"","*":"Melanin"},{"ns":0,"exists":"","*":"Metaplasia"},{"ns":0,"exists":"","*":"Metastasis"},{"ns":0,"exists":"","*":"Microbiological culture"},{"ns":0,"exists":"","*":"Minimal residual disease"},{"ns":0,"exists":"","*":"Molecular pathology"},{"ns":0,"exists":"","*":"Nasopharynx cancer"},{"ns":0,"exists":"","*":"Necrosis"},{"ns":0,"exists":"","*":"Neoplasia"},{"ns":0,"exists":"","*":"Neoplasm"},{"ns":0,"exists":"","*":"Nervous system neoplasm"},{"ns":0,"exists":"","*":"Nucleosome"},{"ns":0,"exists":"","*":"Oncogene"},{"ns":0,"exists":"","*":"Oncology"},{"ns":0,"exists":"","*":"Oncovirus"},{"ns":0,"exists":"","*":"Oral and maxillofacial pathology"},{"ns":0,"exists":"","*":"Oral cancer"},{"ns":0,"exists":"","*":"Papilloma"},{"ns":0,"exists":"","*":"Paraneoplastic syndrome"},{"ns":0,"exists":"","*":"Pathogenesis"},{"ns":0,"exists":"","*":"Pathology"},{"ns":0,"exists":"","*":"Phagocyte"},{"ns":0,"exists":"","*":"Pigment"},{"ns":0,"exists":"","*":"Polymerase chain reaction"},{"ns":0,"exists":"","*":"Positron emission tomography"},{"ns":0,"exists":"","*":"Precancerous condition"},{"ns":0,"exists":"","*":"Primary tumor"},{"ns":0,"exists":"","*":"Programmed cell death"},{"ns":0,"exists":"","*":"Prostate cancer staging"},{"ns":0,"exists":"","*":"Pseudocyst"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Pyknosis"},{"ns":0,"exists":"","*":"Radiation therapy"},{"ns":0,"exists":"","*":"Sarcoma"},{"ns":0,"exists":"","*":"Sentinel lymph node"},{"ns":0,"exists":"","*":"Serology"},{"ns":0,"exists":"","*":"Serum (blood)"},{"ns":0,"exists":"","*":"Single-nucleotide polymorphism"},{"ns":0,"exists":"","*":"Skin cancer"},{"ns":0,"exists":"","*":"Squamous metaplasia"},{"ns":0,"exists":"","*":"Steatosis"},{"ns":0,"exists":"","*":"Surgery"},{"ns":0,"exists":"","*":"Surgical pathology"},{"ns":0,"exists":"","*":"TNM staging system"},{"ns":0,"exists":"","*":"Transfusion medicine"},{"ns":0,"exists":"","*":"Tumor"},{"ns":0,"exists":"","*":"Tumor suppressor gene"},{"ns":0,"exists":"","*":"Urogenital neoplasm"},{"ns":0,"exists":"","*":"Wound healing"},{"ns":0,"*":"Cambridge Epigenetix"},{"ns":11,"exists":"","*":"Template talk:Pathology"},{"ns":11,"exists":"","*":"Template talk:Tumors"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Pathology"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Tumors"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Arguments"}],"images":["Lock-red-alt.svg","Lock-green.svg","CtDNA_in_circulation.png"],"externallinks":["//doi.org/10.1016/j.cancergen.2013.01.005","//www.ncbi.nlm.nih.gov/pubmed/23491080","https://www.nature.com/articles/nrc3066","//doi.org/10.1038/nrc3066","//www.ncbi.nlm.nih.gov/pubmed/21562580","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1173871","//www.ncbi.nlm.nih.gov/pubmed/4634816","https://www.sciencedirect.com/science/article/pii/S0009898101006659","//doi.org/10.1016/S0009-8981(01)00665-9","//www.ncbi.nlm.nih.gov/pubmed/11694251","http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=1149042","//www.ncbi.nlm.nih.gov/pubmed/1149042","//www.ncbi.nlm.nih.gov/pmc/articles/PMC426778","//doi.org/10.1073/pnas.69.7.1685","//www.ncbi.nlm.nih.gov/pubmed/4505646","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3708119","//doi.org/10.1002/ijc.28030","//www.ncbi.nlm.nih.gov/pubmed/23319339","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2952865","//doi.org/10.1093/nar/gkq421","//www.ncbi.nlm.nih.gov/pubmed/20494973","https://www.tandfonline.com/doi/full/10.1080/08916930701358826","//doi.org/10.1080/08916930701358826","//www.ncbi.nlm.nih.gov/pubmed/17516210","//doi.org/10.1016/j.cca.2009.02.018","//www.ncbi.nlm.nih.gov/pubmed/19281804","//doi.org/10.1016/j.clinbiochem.2013.06.002","//www.ncbi.nlm.nih.gov/pubmed/23769817","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4769175","//doi.org/10.1371/journal.pone.0150197","//www.ncbi.nlm.nih.gov/pubmed/26918901","//doi.org/10.1016/j.lungcan.2013.08.014","//www.ncbi.nlm.nih.gov/pubmed/24007628","//doi.org/10.1046/j.1537-2995.2001.41020276.x","//www.ncbi.nlm.nih.gov/pubmed/11239235","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4823888","//doi.org/10.1186/s40880-016-0092-4","//www.ncbi.nlm.nih.gov/pubmed/27056366","//doi.org/10.1373/clinchem.2014.222679","//www.ncbi.nlm.nih.gov/pubmed/25388429","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3641759","//doi.org/10.1126/scitranslmed.3004742","//www.ncbi.nlm.nih.gov/pubmed/23197571","//www.ncbi.nlm.nih.gov/pubmed/5988180","//www.ncbi.nlm.nih.gov/pubmed/1975200","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5630683","//doi.org/10.1038/cr.2017.121","//www.ncbi.nlm.nih.gov/pubmed/28925386","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5630676","//doi.org/10.1038/cr.2017.106","//www.ncbi.nlm.nih.gov/pubmed/28820176","https://www.sciencedirect.com/science/article/pii/S0959437X17300011","//doi.org/10.1016/j.gde.2016.12.003","//www.ncbi.nlm.nih.gov/pubmed/28126649","//www.ncbi.nlm.nih.gov/pmc/articles/PMC166396","//doi.org/10.1073/pnas.1133470100","//www.ncbi.nlm.nih.gov/pubmed/12857956","//doi.org/10.1038/nmeth898","//www.ncbi.nlm.nih.gov/pubmed/16791214","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4016134","//doi.org/10.1038/nm.3519","//www.ncbi.nlm.nih.gov/pubmed/24705333","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4907374","//doi.org/10.1038/nbt.3520","//www.ncbi.nlm.nih.gov/pubmed/27018799","//doi.org/10.1126/scitranslmed.3003726","//www.ncbi.nlm.nih.gov/pubmed/22649089","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3111315","//doi.org/10.1073/pnas.1105422108","//www.ncbi.nlm.nih.gov/pubmed/21586637","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4271547","//doi.org/10.1038/nprot.2014.170","//www.ncbi.nlm.nih.gov/pubmed/25299156","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4913179","//doi.org/10.1016/j.csbj.2016.05.004","//www.ncbi.nlm.nih.gov/pubmed/27358717","//doi.org/10.1038/nrclinonc.2013.110","//www.ncbi.nlm.nih.gov/pubmed/23836314","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4659935","//doi.org/10.1038/ncomms9760","//www.ncbi.nlm.nih.gov/pubmed/26530965","https://www.genome.gov/27556716","http://www.medscape.com/viewarticle/835140","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4356857","//doi.org/10.3978/j.issn.2305-5839.2015.01.16","//www.ncbi.nlm.nih.gov/pubmed/25815297","https://www.clinicalomics.com/articles/teasing-out-circulating-tumor-dna/1491"],"sections":[{"toclevel":1,"level":"2","line":"Methods","number":"1","index":"1","fromtitle":"Circulating_tumor_DNA","byteoffset":5762,"anchor":"Methods"},{"toclevel":2,"level":"3","line":"Pre-analytical Considerations","number":"1.1","index":"2","fromtitle":"Circulating_tumor_DNA","byteoffset":5777,"anchor":"Pre-analytical_Considerations"},{"toclevel":2,"level":"3","line":"Extraction of ctDNA","number":"1.2","index":"3","fromtitle":"Circulating_tumor_DNA","byteoffset":8840,"anchor":"Extraction_of_ctDNA"},{"toclevel":2,"level":"3","line":"Analysis of ctDNA","number":"1.3","index":"4","fromtitle":"Circulating_tumor_DNA","byteoffset":10197,"anchor":"Analysis_of_ctDNA"},{"toclevel":3,"level":"4","line":"Untargeted approaches","number":"1.3.1","index":"5","fromtitle":"Circulating_tumor_DNA","byteoffset":10544,"anchor":"Untargeted_approaches"},{"toclevel":4,"level":"5","line":"Digital Karyotyping","number":"1.3.1.1","index":"6","fromtitle":"Circulating_tumor_DNA","byteoffset":12377,"anchor":"Digital_Karyotyping"},{"toclevel":4,"level":"5","line":"Personalized analysis of rearranged ends (PARE)","number":"1.3.1.2","index":"7","fromtitle":"Circulating_tumor_DNA","byteoffset":13392,"anchor":"Personalized_analysis_of_rearranged_ends_(PARE)"},{"toclevel":4,"level":"5","line":"DNA Methylation and Hydroxymethylation","number":"1.3.1.3","index":"8","fromtitle":"Circulating_tumor_DNA","byteoffset":13766,"anchor":"DNA_Methylation_and_Hydroxymethylation"},{"toclevel":3,"level":"4","line":"Targeted approaches","number":"1.3.2","index":"9","fromtitle":"Circulating_tumor_DNA","byteoffset":16600,"anchor":"Targeted_approaches"},{"toclevel":4,"level":"5","line":"Digital droplet PCR (ddPCR)","number":"1.3.2.1","index":"10","fromtitle":"Circulating_tumor_DNA","byteoffset":18476,"anchor":"Digital_droplet_PCR_(ddPCR)"},{"toclevel":4,"level":"5","line":"Beads, Emulsification, Amplification, and Magnetics (BEAMing)","number":"1.3.2.2","index":"11","fromtitle":"Circulating_tumor_DNA","byteoffset":19254,"anchor":"Beads,_Emulsification,_Amplification,_and_Magnetics_(BEAMing)"},{"toclevel":4,"level":"5","line":"CAncer Personalized Profiling by deep Sequencing (CAPP-Seq)","number":"1.3.2.3","index":"12","fromtitle":"Circulating_tumor_DNA","byteoffset":21340,"anchor":"CAncer_Personalized_Profiling_by_deep_Sequencing_(CAPP-Seq)"},{"toclevel":4,"level":"5","line":"Tagged AMplicon deep Sequencing (TAM-Seq)","number":"1.3.2.4","index":"13","fromtitle":"Circulating_tumor_DNA","byteoffset":22987,"anchor":"Tagged_AMplicon_deep_Sequencing_(TAM-Seq)"},{"toclevel":4,"level":"5","line":"Safe-Sequencing (Safe-Seq)","number":"1.3.2.5","index":"14","fromtitle":"Circulating_tumor_DNA","byteoffset":24076,"anchor":"Safe-Sequencing_(Safe-Seq)"},{"toclevel":4,"level":"5","line":"Duplex sequencing","number":"1.3.2.6","index":"15","fromtitle":"Circulating_tumor_DNA","byteoffset":25344,"anchor":"Duplex_sequencing"},{"toclevel":4,"level":"5","line":"Integrated Digital Error Suppression (iDES)-enhanced CAPP-Seq","number":"1.3.2.7","index":"16","fromtitle":"Circulating_tumor_DNA","byteoffset":26649,"anchor":"Integrated_Digital_Error_Suppression_(iDES)-enhanced_CAPP-Seq"},{"toclevel":1,"level":"2","line":"Considerations","number":"2","index":"17","fromtitle":"Circulating_tumor_DNA","byteoffset":27149,"anchor":"Considerations"},{"toclevel":2,"level":"3","line":"\u201cNormal\u201d vs tumor DNA detection","number":"2.1","index":"18","fromtitle":"Circulating_tumor_DNA","byteoffset":27171,"anchor":"\u201cNormal\u201d_vs_tumor_DNA_detection"},{"toclevel":1,"level":"2","line":"Research","number":"3","index":"19","fromtitle":"Circulating_tumor_DNA","byteoffset":27614,"anchor":"Research"},{"toclevel":2,"level":"3","line":"ctDNA in cancer screening","number":"3.1","index":"20","fromtitle":"Circulating_tumor_DNA","byteoffset":27627,"anchor":"ctDNA_in_cancer_screening"},{"toclevel":2,"level":"3","line":"ctDNA in cancer monitoring","number":"3.2","index":"21","fromtitle":"Circulating_tumor_DNA","byteoffset":28266,"anchor":"ctDNA_in_cancer_monitoring"},{"toclevel":2,"level":"3","line":"ctDNA as a prognostic biomarker","number":"3.3","index":"22","fromtitle":"Circulating_tumor_DNA","byteoffset":29525,"anchor":"ctDNA_as_a_prognostic_biomarker"},{"toclevel":2,"level":"3","line":"Cancer research","number":"3.4","index":"23","fromtitle":"Circulating_tumor_DNA","byteoffset":30742,"anchor":"Cancer_research"},{"toclevel":2,"level":"3","line":"Challenges for implementation","number":"3.5","index":"24","fromtitle":"Circulating_tumor_DNA","byteoffset":32236,"anchor":"Challenges_for_implementation"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"25","fromtitle":"Circulating_tumor_DNA","byteoffset":33046,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"26","fromtitle":"Circulating_tumor_DNA","byteoffset":33094,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"6","index":"27","fromtitle":"Circulating_tumor_DNA","byteoffset":33124,"anchor":"Further_reading"}],"parsewarnings":[],"displaytitle":"Circulating tumor DNA","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q19596321"}]}}